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LASER COAGULATION IN COMPLICATED MONOCHORIONIC 
PREGNANCIES. SUMMARY  
 
 
Monochorionic pregnancies are found in 1 in 200 births, but the incidence is 
increasing because of the widespread use of assisted reproductive technology. 
Monochorionic twins, compared to dichorionic twins, have a considerably higher 
risk of pregnancy complications that are dues to the process of splitting of the 
single embryonic mass [congenital abnormalities, conjoint twins, selective fetal 
growth restriction (sFGR)] and the communicating placental vessels between 
the two circulations [twin-to-twin transfusion syndrome (TTTS), twin reversed 
arterial perfusion (TRAP) sequence, twin anemia polycythemia sequence 
(TAPS)].  
 
This thesis reports on the outcome of pregnancies with sFGR (with and without 
superimposed TTTS) treated by endoscopic laser separation of the inter-twin 
communicating placental vessels.  
 
Triplet pregnancies in which two or all three fetuses are monochorionic, are at 
very high risk of perinatal death. The incidence of dichorionic triamniotic 
pregnancies has dramatically increased following the practice of IVF with 
delayed transfer of two embryos. 
 
This thesis reports on the outcome of monochorionic and dichorionic triplet 
pregnancies complicated by TTTS (with and without sFGR) treated by 
endoscopic laser separation of the communicating placental vessels. The 
thesis also reports on the development of a first-trimester technique for embryo 
reduction of one of the two monochorionic twins by ultrasound-guided interstitial 
laser ablation of the pelvic vessels. 
 
Professor Kypros Herodotou Nicolaides 
King’s College Hospital School of Medicine  
London, England 
I confirm that Dr Gergana Peeva has carried out under my supervision the 
studies presented in the Thesis: Laser coagulation in complicated 
monochorionic pregnancies. 
I have read the Thesis and I agree for the Thesis to be presented to the 
Tribunal for the degree of Doctor of Philosophy in Medicine.
Professor Kypros Herodotou Nicolaides 
London, March 2018 
  
Professor María de la Calle Fernández-Miranda 
Universidad Autónoma de Madrid,  
Madrid, Spain  
I confirm that Dr Gergana Peeva has carried out under my supervision the 
studies presented in the Thesis: Laser coagulation in complicated 
monochorionic pregnancies. 
I have read the Thesis and I agree for the Thesis to be presented to the 
Tribunal for the degree of Doctor of Philosophy in Medicine.
Professor María de la Calle Fernández-Miranda 
Madrid, March 2018 
!10
ACKNOWLEDGEMENTS 
I would like to express my sincere gratitude to Professor Kypros Nicolaides, who has 
been a tremendous mentor and a good friend for me. I would like to thank him for 
encouraging my passion for research and for allowing me to grow my knowledge, 
giving me the opportunity to learn from him not only fetal medicine and surgery but 
also to rethink the real values in life. His advice on both research as well as on my 
career have been invaluable. He has been the biggest inspiration in my life and I 
cannot thank him enough for this. 
I would like to express my special appreciation and thanks to my dear friend Mar Gil 
and her family for the endless support, patient guidance and generously spent time 
throughout the whole process. Without her precious help it would not have been 
possible to carry out this thesis. 
I also want to thank all the co-authors of the studies, whose knowledge, energy and 
enthusiasm were critical to this effort. And of course, all the fellows from Harris 
Birthright Research Centre, scanning, collecting data, recruiting patients and getting 
outcomes. Without their hard work the completion of these studies would not have 
been possible. I learnt a lot from all of you. 
I would like to thank my tutors, Professor Doichin Angelov, PD Dr. Dr. Yves Garnier, 
Dr. Annette Mosel, Dr. Helga Brachmann and Dr. Eduard Vlajkovic for their valuable 
guidance and enthusiastic encouragement throughout my career. They have 
provided me with the tools that I needed to choose the right direction in my 
profession, that I adore so much. 
My grateful thanks are also extended to all my friends over the world who supported 
me throughout my studies. 
!11
A special word of thanks also goes to my beloved family, especially my wonderful 
parents Siyana and Pejcho, my amazing brother Miro and my inspiring sister in law 
Julia. I thank them for supporting me and encouraging me throughout this experience 
and in everything I do. I thank them for always being there for me in sunny and rainy 
days and for never giving up their faith in me. I love you. I hope I have made you 
proud. 
!12
AGRADECIMIENTOS  
Me gustaría expresar mi más sincera gratitud al Profesor Nicolaides, has sido y eres 
un gran mentor y un buen amigo para mí. Quiero agradecerte el haber acrecentado 
mi pasión por la investigación y mejorado de tal manera mi conocimiento que, no 
solo me has enseñado medicina y cirugía fetal, sino que también me has hecho 
replantarme los verdaderos valores de la vida. Tus consejos a lo largo de estos años 
no tienen precio. Eres la mayor inspiración en mi vida y nunca podré agradecerte lo 
suficiente.  
Me gustaría  expresar mi cariño y agradecimiento a mi buena amiga Mar Gil y a su 
familia por su apoyo infinito, su guía paciente y la generosidad mostrada durante 
todo este proceso. Sin vuestra preciada ayuda no habría sido posible realizar esta 
tesis. ¡Gracias! 
También quiero agradecer a todos los co-autores de los artículos, cuyo 
conocimiento, energía y entusiasmo han sido claves para su desarrollo. Y por 
supuesto, darle las gracias a todos los fellows de Harris Birthright Research 
Centre que han trabajado para el buen curso de los estudios. Sin su gran esfuerzo 
ninguno de estos estudios hubiera sido posible. He aprendido mucho de todos.   
Además, me gustaría agradecer a mis tutores, el Profesor Doichin Angelov, PD Dr. 
Dr. Yves Garnier, Dr. Annette Mosel, Dr. Helga Brachmann y Dr. Eduard Vlajkovic por 
su valiosa guía y entusiasta apoyo durante mi carrera. Definitivamente, me habéis 
facilitado las herramientas necesarias para elegir la dirección correcta en esta 
profesión que adoro tanto. 
!13
Mi agradecimiento también se extiende a todos mis amigos del mundo que me 
apoyaron a lo largo de mis estudios. 
Un agradecimiento muy especial es para mi querida familia, especialmente a mis 
maravillosos padres Sijana y Pejcho, a mi incredible hermano Miro y a mi cuñada 
inspiradora Julia. Gracias por apoyarme en todo, no puedo agradeceros lo suficiente 
vuestros ánimos durante esta experiencia. Gracias por estar siempre ahí, en los días 
buenos y en los malos, y por no perder nunca vuestra fe en mí. Os quiero. Espero 
que hoy estéis orgullosos. 
!14
!15
CONTENTS 
 
CHAPTER 1  INTRODUCTION          25 
                     
1.1 Presentación en Español         27 
1.2 Chorionicity and zygosity             28 
1.2.1  Overview             28 
1.2.2 Prenatal assessment of chorionicity          30 
1.2.3 Impact of ART of monozygotic twinning          32 
1.2.4  Consequences of monochorionicity          32  
1.3 Twin-to-twin transfusion syndrome         39 
1.3.1 Classification             39 
1.3.2  Management             40  
1.3.3 Outcome after laser surgery          43  
1.3.4 Long-term neurodevelopmental outcome for TTTS       46 
1.4 Selective fetal growth restriction         47 
1.4.1 Classification             47 
1.4.2  Management             48 
1.5 Management of triplet pregnancies diagnosed in the first trimester  51 
1.5.1 Incidence of triplet pregnancies           51 
1.5.2 Consequences of expectant management and embryo reduction     51 
1.5.3 Intrafetal laser for embryo reduction of dichorionic triplets to  
dichorionic twins            54 
1.6 Objectives              55 
!16
CONTENTS 
CHAPTER 2  PUBLISHED STUDIES            57 
STUDY 1                 63 
Peeva G, Bower S, Orosz L, Chaveeva P, Akolekar R, Nicolaides KH: Endoscopic 
placental laser coagulation in monochorionic diamniotic twins with type II selective 
fetal growth restriction. Fetal Diagn Ther 2015; 38: 86-93.  
STUDY 2                73 
Peeva G, Chaveeva P, Gil Guevara E, Akolekar R, Nicolaides KH: Endoscopic 
placental laser coagulation in dichorionic and monochorionic triplet pregnancies. 
Fetal Diagn Ther 2016; 40: 174-180. 
STUDY 3                 83 
Chaveeva P, Peeva G, Gil Pugliese S, Shterev A, Nicolaides KH: Intrafetal laser for 
embryo reduction from dichorionic triplets to dichorionic twins. Ultrasound Obstet 
Gynecol 2017 Aug 9. doi: 10.1002/uog.18834. 
  
CHAPTER 3    SUMMARY              89 
CHAPTER 4    DISCUSSION            97 
CHAPTER 5  CONCLUSIONS            101 
CHAPTER 6   REFERENCES          109 
!17
!18
ABBREVIATIONS 
AA  arterioarterial 
AEDF  absent end-diastolic flow 
AFDV  absent flow ductus venosus  
AREDF absent or reversed end diastolic flow 
ART  artificial reproductive technologies  
AV  arteriovenous  
BCTA   bicoriales triamniónicas 
CIRs  crecimiento intrauterino restrictivo selectivo  
CIRs-II  crecimiento intrauterino restrictivo selectivo tipo II 
cm  centimetre 
cm/s  centimetre per second 
DC  dichorionic 
DCDA  dichorionic-diamniotic  
DCT  dichorionic triplet  
DVP   deepest vertical pool  
ER  embryo reduction  
FFTS  feto-fetal transfusion syndrome  
FGR  fetal growth restriction 
KCL  potassium chloride, cloruro de potasio  
MC  monochorionic 
MCA  middle cerebral artery 
MCBA  monocoriales biamniónicas 
!19
ABBREVIATIONS 
MCDA  monochorionic-diamniotic  
MCMA  monochorionic-monoamniotic  
MoM  multiple of median 
NDI  neurodevelopmental impairment  
PSV  peak systolic velocity 
PTB  preterm birth 
PUVF  pulsatile umbilical venous flow  
RE  reducción embrionaria 
REDV  reverse end-diastolic flow in the umbilical artery  
RFDV  reversed flow in ductus venosus  
sFGR  selective fetal growth restriction  
sFGR-II selective fetal growth restriction type II 
STFF  síndrome de transfusión feto-fetal  
TA  triamniotic  
TAPS  twin anemia polycythemia sequence  
TCT  trichorionic triplets  
TRA  reproducción asistida 
TRAP  twin reversed arterial perfusion 
TTTS  twin-to-twin transfusion syndrome  
UA  umbilical artery  
VV  venovenous  
!20
LIST OF TABLES 
 
Table 1 Complications in monochorionic twins due to unique placentation presented 
in percentage of overall incidence of monochorionic twin pregnancies. 
Table 2 Reference values of peak systolic velocity (cm/s) of the middle cerebral 
artery.  
Table 3 Staging of TTTS based on ultrasound findings.  
Table 4 Laser therapy and serial amnioreduction as treatment for twin-twin 
transfusion syndrome.  
Table 5 Comparison between the two techniques for laser coagulation of the 
communicating intertwin vascular anastomosis. 
Table 6 Survival in stage I TTTS treated by endoscopic laser coagulation. 
Table 7 Survival in stage II TTTS treated by endoscopic laser coagulation. 
Table 8 Survival in stage III and stage IV TTTS treated by endoscopic laser 
coagulation.  
Table 9 Reports on outcome of MC twin pregnancies with type I sFGR managed 
expectantly. 
Table 10 Reports on management of MC twin pregnancies with type II sFGR. 
Table 11 Outcome of MC twin pregnancies with type III sFGR without superimposed 
TTTS managed expectantly. 
!21
LIST OF TABLES 
Table 12 Studies reporting on the management of TCT pregnancies. 
Table 13 Studies reporting on the management of DCT pregnancies. 
!22
LIST OF FIGURES 
Figure 1 Possible relations of chronicity in monozygotic twins based on the cleavage 
timing 
Figure 2 Ultrasound images in the first trimester of a DCDA pregnancy with λ-sign and 
MCDA pregnancy with T-sign  
Figure 3 Histological section of DCDA and MCDA placenta 
Figure 4 Normal MC placenta and TTTS placenta treated with amnioreduction  
Figure 5 Doppler assessment of flow in the fetal middle cerebral artery and typical 
placenta appearance in TAPS 
Figure 6 TRAP sequence, pulsed Doppler of the perfused twin demonstrating reversal 
of flow in the umbilical artery and TRAP appearance post delivery  
Figure 7 Schematic representation of laser techniques and TTTS placenta treated 
with laser using the Solomon technique 
Figure 8 Doppler examination of umbilical artery in sFGR with positive EDF, absent 
EDF and intermittent AREDF  
!23
INTRODUCTION 
!  
!24
INTRODUCTION 
!  
!25
1. INTRODUCTION
1.1 Presentación en Español 
1.2 Chorionicity and zygosity 
1.2.1  Overview 
1.2.2 Prenatal assessment of chorionicity 
1.2.3 Impact of ART of monozygotic twinning 
1.2.4  Consequences of monochorionicity 
1.3 Twin-to-twin transfusion syndrome 
1.3.1 Classification 
1.3.2  Management 
1.3.3 Outcome after laser surgery 
1.3.4 Neurodevelopmental outcome 
1.4 Selective fetal growth restriction 
1.4.1 Classification 
1.4.2  Management 
1.5 Management of triplet pregnancies diagnosed in the first 
trimester 
1.5.1 Incidence of triplet pregnancies  
1.5.2 Consequences of expectant management and embryo 
reduction 
1.5.3 Intrafetal laser for embryo reduction of dichorionic triplets to 
dichorionic twins 
1.6 Objectives 
INTRODUCTION 
!  
  
!26
INTRODUCTION 
!  
1.1 PRESENTACIÓN EN ESPAÑOL 
La prevalencia de la gestación monocorial es de 1 en 200 nacimientos, pero su incidencia 
está en aumento consecuencia del rápido aumento en el uso de las técnicas de 
reproducción asistida (TRA). Los gemelos monocoriales, en contraste con los bicoriales, 
tienen un riesgo considerablemente mayor de complicaciones del embarazo debidas al 
proceso de separación de una masa embrionaria única (anomalías congénitas, gemelos 
siameses, crecimiento intrauterino restrictivo selectivo (CIRs)) y a la presencia de vasos 
placentarios comunicantes entre las dos circulaciones fetales [síndrome de transfusión feto-
fetal (STFF), la secuencia TRAP (twin reversed arterial perfusion) y la secuencia TAPS (twin 
anemia polycythemia sequence).  
Esta tesis trata el resultado perinatal de gestaciones con CIRs (con y sin STFF 
sobreañadido) tratadas con láser endoscópico para la separación de los vasos placentarios 
comunicantes. 
Las gestaciones triples en las que dos o los tres fetos son monocoriales presentan un 
riesgo muy alto de muerte perinatal. La incidencia de gestaciones bicoriales triamniónicas 
(BCTA) ha aumentado considerablemente consecuencia del aumento de las TRA con la 
transferencia diferida de dos embriones.  
Esta tesis trata el resultado perinatal de gestaciones triples monocoriales y dicoriales 
complicadas con STFF (con y sin CIRs) tratadas con láser endoscópico para la separación 
de los vasos comunicantes. Esta tesis también analiza el desarrollo de una técnica para 
embrioreducción de uno de los dos gemelos monocoriales en el primer trimestre mediante 
ablación con láser intersticial de los vasos pélvicos fetales. 
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1.2 CHORIONICITY AND ZYGOSITY 
1.2.1 Overview 
The incidence of multiple pregnancies is rising, mainly due to delayed childbirth and 
advanced maternal age at conception and the resultant widespread use of assisted 
reproduction techniques (National Collaborating Centre for Women’s and Children’s Health 
2011).  About 1 in 90 spontaneous conceptions results in the birth of twins, however due to 
artificial reproductive technologies (ART) the rate of twining has increased by 75% over the 
last 3 decades and overall twins constitute 2-4% of all births (Ananth et al., 2012). 
Twinning can be categorised according to zygosity and chorionicity. Zygosity refers to the 
type of conception. Chorionicity refers to the type of placentation and is closely related to 
zygosity. Although all monochorionic (MC) twins are monozygotic, and all unlike-sex twins 
are dizygotic, zygosity remains unknown by clinical means in all like-sex dichorionic twins. 
Dizygotic twins (non-identical, fraternal) twins (70% of all twins) result from multiple ovulation 
with synchronous fertilization of two ova by two sperm cells. The causes of dizygotic twinning 
are multifactorial. Maternal family history, ethnicity, age, gonadotropin levels, use of artificial 
conception technology and dietary factors are all likely to play a role (Weber et al., 2010; 
Shur et al., 2009). Dizygotic twins always have separate placentas and are therefore per 
definition dichorionic. 
Monozygotic twins (identical, 30% of all twins) result from division of a zygote originating from 
the fertilization of one ovum by one sperm cell (Hall et al., 2003). The exact origin of 
monozygotic twinning remains unknown. The single fertilised egg or zygote may divide into 
two embryos at any stage between 1 and 16 days after fertilisation. The time at which the 
embryo divides is a critical factor in subsequent placental development (Hall et al., 2003; 
Figure 1). The process of division is called cleavage. If cleavage occurs early (0-3 days) after 
fertilisation (25-30% of cases), the pregnancy develops into dichorionic-diamniotic twins 
(DCDA). Division at 4-7 days after fertilisation (70-75% of cases) when the chorionic sac has 
already developed will result in monochorionic-diamniotic twins (MCDA). Division at 8-13 
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days after fertilization (1-2% of monozygotic twins), the amnion has developed and therefore 
the cleavage at this stage results in monochorionic-monoamniotic twins (MCMA). Later 
zygotic splitting (14-16 days), when the development of the embryo has already 
commenced, results in conjoined monochorionic-monoamniotic twinning.   
Figure 1. Possible relations of chronicity in monozygotic twins based on the cleavage timing 
(Dufendach, 2008). 
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It is neither zygosity nor mode of conception, but chronicity that is the main determinant for 
pregnancy outcome (Benirschke et al, 1973; Neilson et al., 1989; Bejar et al., 1990). 
1.2.2 Prenatal assessment of chorionicity 
Accurate determination of chronicity is of paramount importance for the optimal 
management of twin pregnancies. Therefore the distinction between a high-risk 
monochorionic and lower risk dichorionic twin pair should be performed as early as possible 
in the gestation, preferably in the first trimester. A number of different markers have been 
proposed for ultrasound determination of chorionicity (Scardo et al., 1995). Accuracy of 
antenatal chorionicity determination has been reported to be between 75% and 100%. This 
variation can be attributed not only to the use of different ultrasound markers, but also to the 
timing of scans and the lack of placental histology to confirm chorionicity (Scardo et al., 
1995; Sepulveda et al., 1996). The most accurate markers of chorionicity (>99%) appear to 
be the combination of placental number with the use of the membrane T or λ-signs for a 
single placental mass at 11-13 weeks gestation (Sepulveda et al., 1996; Dias et al., 2011). 
In dichorionic (DC) twins the inter-twin membrane is formed by one thick layer in the middle 
consisting of the two adjacent chorionic membranes with thin layers of amniotic membrane 
on each side (Figures 2 and 3). Sonographically this appears as the so-called λ-sign 
(Sepulveda et al., 1996). Also the yolk sacs are in separate exocoelomic cavities.  
In monochorionic-diamniotic twins the dividing membrane consists only with the two fused 
amniotic membranes and has been described as the T-sign (Sepulveda et al., 1996).  With 
advancing gestation there is regression of the chorion leave and the ‘lambda’ sign becomes 
progressively more difficult to identify. Thus by 20 weeks only 85% of DC pregnancies 
demonstrate the λ-sign. 
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Figure 2. Ultrasound images in the first trimester of a DCDA pregnancy with λ-sign (left) and MCDA 
pregnancy with T-sign (right). 
 
Figure 3. Histological section of DCDA placenta: thin cuboidal layer of amnion on each side and the 
two chorions plastered together in the centre (left; Pathology Outlines 2011). Histological section of 
MCDA placenta: thin cuboidal layer of amnion on each surface without visible chorion in-between 
(right; Baergen et al., 2015) 
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It is important to emphasize line that amnionicity cannot be predicted accurately by the 
number of the yolk sacs. Indeed the majority (85%) of diamniotic twins have two yolk sacs, 
whereas monoamniotic twins have a single yolk sac (Shen et al., 2006); however, rare 
exceptions have been described (Corbett et al., 2012). 
1.2.3 Impact of ART of monozygotic twinning 
In spontaneous conceptions the rate of monozygotic twinning is 0.4 - 0.45% (MacGillivray 
1986; Derom et al. 1987), whereas the rate after assisted reproduction is increased to 2.1 - 
2.2%. Factors, which have significant impact on the monozygotic twinning in assisted 
reproduction, are younger oocyte age (female age at time of retrieval <35 years), fresh 
embryo transfer and extended culture (defined as noncleavage embryos transferred on / 
after day 4).  In fact, the risk for monozygotic twinning is increased by 50% after day 5 
transfer (blastocyst stage) than after day 3 transfers (Knoppmann et al., 2014; Mateizel et al., 
2016).  
1.2.4 Consequences of monochorionicity 
The placenta in monochorionic twins is unique. Both fetuses share a single placenta and 
vascular anastomoses on the fetal surface connect the blood circulations of both twins. 
Through these anastomoses, there is a continuous exchange of blood between the twins 
(Couck et al., 2016). Therefore the monochorionic placenta can be divided into three parts, 
one part, which belongs to one twin, second which belongs to the co-twin and third which 
both monochorionic twins are sharing via anastomoses.  
Anastomoses can be of three types: arterioarterial, arteriovenous, and venovenous (Figure 
4). Arterioarterial (AA) and venovenous (VV) anastomoses are superficial and bidirectional 
anastomoses. “Superficial” refers to the fact that they are visible on the surface of the 
chorionic plate, forming direct communications between the arteries and veins. “Bidirectional” 
means that they allow flow in both directions depending on the relative intertwin vascular 
pressure gradients. Most monochorionic placentas typically have only one AA anastomosis. 
VV anastomoses are more rare and seen in only about 25% of monochorionic placentas. 
Arteriovenous (AV) anastomoses are very common in a monochorionic placenta and present 
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as deep and unidirectional anastomoses. “Deep” refers to the fact that the anastomosis itself 
occurs at the capillary level within a shared placental lobule. “Unidirectional” means that they 
allow flow in one direction only. It receives its arterial supply from one twin and gives its 
venous (well-oxygenated) drainage to the other.  Because of their unidirectional nature, AV 
anastomoses can create a transfusion imbalance, unless an oppositely directed transfusion 
by other superficial or deep anastomoses provides adequate compensation (Lewi et al., 
2013). 
 
Figure 4. Normal MC placenta showing several AV and VA anastomoses (green and white stars, 
respectively) and 2 AA anastomoses (blue stars; left). TTTS placenta treated with amnioreduction 
showing several AV anastomoses (green stars) and VA anastomoses (white stars) and 1 AA 
anastomosis (blue star; right; Reprinted from Zhao et al., 2014). 
Imbalances in this intertwin exchange are often the cause of severe and specific for 
monochorionic twins’ complications, such as twin-to-twin transfusion syndrome (TTTS), 
selective fetal growth restriction (sFGR), twin reversed arterial perfusion (TRAP) and twin 
anemia polycythemia sequence (TAPS) (Table 1). 
Major congenital anomalies are more common in monochorionic twin pregnancies and 
occur in about 6% of pairs (Sperling et al., 2007). Concordance (both twins similarly 
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affected) for a structural anomaly is rare. Several hypotheses exist to explain this increased 
incidence. Possibly the zygotic splitting itself is teratogenic, resulting in abnormalities, such 
as midline defects (Table 1). 
Table 1. Complications in monochorionic twins due to unique placentation presented in percentage of 
overall incidence of monochorionic twin pregnancies. 
Furthermore, in monochorionic twin gestations, transfusion imbalances through the 
anastomoses during embryogenesis or during later fetal life may account for at least part of 
the cardiac or brain anomalies observed in these pregnancies. As such, the prevalence of 
congenital cardiac anomalies in monochorionic twins has been reported to be 2.3% in those 
without TTTS and 7% in those with TTTS, compared to 0.6% in the general population 
(Lewi et al., 2013).  
Due to the shared circulation within the common placenta, the well being of one twin 
critically depends on that of the other. As consequence of this, a single death may lead to 
double demise in about 15% or antenatal brain damage with neurodevelopmental 
impairment in another 25%, because of acute exsanguination of the surviving co-twin into its 
demised twin’s circulation, in addition to a 68% risk of preterm birth (Hillman et al., 2011). 
Complications in MC twins % Study
Twin-to-twin transfusion syndrome 15 Sebire et al., 2000
Selective fetal growth restriction 12 Sebire et al., 1997
Twin reversed arterial perfusion 1 Moore et al., 1990
Twin anemia polycythemia sequence
5 Lewi et al., 2008 (spontaneous)
13 Robyr et al., 2006 (post laser)
Discordant anomalies 6 Sperling et al., 2007
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Twin Anemia and Polycythemia Syndrome 
TAPS occurs due to a slow transfusion of blood from the donor to the recipient via few 
minuscule arteriovenous vascular anastomoses leading gradually to highly discordant 
hemoglobin levels. The spontaneous form complicates approximately 5% of all 
monochorionic twin pregnancies (Lewi et al., 2008), whereas the iatrogenic form following 
incomplete laser coagulation of the communicating vessels occurs in approximately 13% of 
the cases (Robyr et al., 2006). TAPS can be diagnosed antenatal based on discordant fetal 
middle cerebral artery peak systolic velocity (MCA-PSV) measurements (Figure 5). The 
normal values of MCA PSV are given in Table 2. The fetal MCA PSV in the anemic fetus is 
increased (>1.5 multiples of median), whereas that in the polycythemic fetus is decreased 
(<1 multiples of the median; Mari et al., 2000, Slaghekke et al., 2010). The placenta of the 
anemic fetus looks thick and hyperechogenic, whereas that of the polycythemic fetus looks 
thin and translucent (Figure 5). 
 
Figure 5. Doppler assessment of flow in the fetal middle cerebral artery (left; FMF) and typical 
placenta appearance in TAPS (right; Reprinted from Slaghekke et al., 2010) 
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Table 2. Reference values of peak systolic velocity (cm/s) of the middle cerebral artery (Mari et al., 
2000). 
Gestational age 
weeks
Peak Systolic Velocity of the Middle Cerebral Artery  (cm/s)
Multiple of Median (MoM)
1 1.5 2
17 22 33 44
18 23 35 46
19 24 36 48
20 25 38 50
21 26 39 52
22 28 42 56
23 29 44 58
24 30 45 60
25 32 48 64
26 33 50 66
27 35 53 70
28 37 56 74
29 38 57 76
30 40 60 80
31 42 63 84
32 44 66 88
33 46 69 92
34 48 72 96
35 50 75 100
36 53 80 106
37 55 83 110
38 58 87 116
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The anemic fetus may have a dilated heart, tricuspid regurgitation and ascites. The liver of 
the polycythemic fetus has a starry sky pattern due to diminished echogenicity of the liver 
parenchyma and an increased brightness of the portal venule walls (FMF website 2017). 
Postnatal, TAPS is defined by hemoglobin discordance of at least 8 g/dl. 
TAPS usually presents in the viable period, so the mortality and morbidity is much lower 
compared to TTTS. The management will mainly depend on and accessibility of the 
equator. Cordocentesis and intrauterine transfusion is an option by gestational age prior to 
30 weeks and persistent discordance in MCA-PSV or a hydrops. Further options depending 
on the gestational age are an elective delivery, a selective reduction, or a re-laser of the 
vascular anastomoses (Lewi et al., 2013). 
Twin Reversed Arterial Perfusion Sequence 
TRAP sequence is a rare condition and complicates about 1% of monochorionic twin 
pregnancies, which results in an incidence of 1: 35,000 pregnancies. In this unique for 
monochorionic placentation condition there is a discordant development or an intrauterine 
demise of one of the monochorionic twins (true parasite) allowing for reversal of blood flow 
from an umbilical artery of the pump twin in a reversed direction into the umbilical artery of 
the perfused twin, via an arterioarterial anastomosis and usually returns via a venovenous 
anastomosis back to the pump twin. The perfused twin’s blood supply is by definition 
deoxygenated and results in variable degrees of deficient development of the head, heart, 
and upper limb structures. Usually, the perfused twin does not have any functional cardiac 
activity, hence also the name “acardiac twin.” TRAP is diagnosed by the detection of color 
Doppler ultrasound showing the reversed blood flow in the umbilical artery (Figure 6; Zhao 
et al., 2014). The acardiac twin is hemodynamically dependent on the pump twin, and its 
continuous growth threatens the survival of the co-twin, either by increasing the risk for the 
development of congestive cardiac failure with subsequent intrauterine death, or due to the 
development of polyhydramnios, preterm premature rupture of membranes, preterm labour 
and premature delivery. The size of the acardiac mass seems to be of prognostic value for 
the survival of the pump twin. The perinatal mortality rate for the healthy co- twin has been 
reported to be in the range 35% to 55% (Hecher et al., 2007). The incidence of 
chromosomal abnormalities, genetic syndromes or fetal defects is not increased. 
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Figure 6. TRAP sequence (left; FMF), pulsed Doppler of the perfused twin (TRAP) demonstrating 
reversal of flow in the umbilical artery (right; Reprinted from Khanduri et al., 2015) and TRAP 
appearance post delivery (right; anomalias congenitas/es.atlaseclamc.org)
Several methods for intrauterine intervention have been developed aiming to improve the 
outcome for the pump twin. In combined data, the survival rate of the pump twin was about 
80% for most techniques, including ablation of umbilical cord vessels by laser or diathermy, 
coagulation of placental anastomoses by laser, or ablation of intrafetal vessels by 
monopolar diathermy, laser, or radiofrequency. However, these survival rates relate to 
pregnancies with TRAP sequence diagnosed at or after 16 weeks’ gestation. The delay in 
intervention between the diagnosis of TRAP sequence at 11-13 weeks until 16-18 weeks is 
associated with spontaneous cessation of flow in the acardiac twin in 60% of cases and in 
about 60% of these there is also death or brain damage in the pump twin. Therefore survival 
may be improved by elective intervention at 12-14 weeks by avoiding the hidden mortality of 
the pump twin until a second trimester intervention and is described to be 77.4% (Chaveeva 
et al., 2014). 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1.3 TWIN-TO-TWIN TRANSFUSION SYNDROME 
1.3.1 Classification 
One of the major complications that may occur in monochorionic pregnancies before fetal 
viability is reached is the onset of severe TTTS, complicating about 10-15% of mid-trimester 
monochorionic twin pregnancies (Sebire et al., 2000; Quintero et al., 1999). Its onset can be 
attributed to a net blood flow from one fetus (the donor twin) to the other (the recipient twin) 
via unidirectional arteriovenous placental anastomoses (Lewi et al., 2013).  
The syndrome is defined sonographically by the presence of a polyhydramnios in the sac of 
one twin (recipient twin) and oligohydramnios in the sac of the other twin (donor twin) 
(Quintero et al., 1999). Whereas the definition of oligohydramnios is world wide accepted as 
deepest vertical pool (DVP) of ≤ 2 cm, there are differences in the description of 
polyhydramnios. Because amniotic fluid increases with gestation, most Europeans adhere 
to the gestational age-dependent cut-off of a DVP ≥ 10 cm after 20 weeks to define the 
degree of polyhydramnios instead of the primary proposed cut-off of vertical deepest pool ≥ 
8 cm (Senat et al., 2004). 
The severity of the disease is classified as stage I if the Doppler findings in the umbilical 
artery and ductus venosus of both fetuses are normal and the bladder of the donor is 
visible, stage II with normal Doppler findings but not visible bladder, stage III with abnormal 
Doppler findings in either twin defined as absent (AEDF) or reverse end-diastolic flow in the 
umbilical artery (REDV), absent (AFDV) or reversed flow in ductus venosus (RFDV) or 
pulsatile umbilical venous flow (PUVF) and stage IV with presence of ascites or hydrops in 
either twin. Stage V is characterised with intrauterine demise of one or both twins. (Table 3; 
Quintero et al., 1999) 
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Table 3. Staging of TTTS based on ultrasound findings.  
* Polyhydramnios: DVP ≥8 cm before 20 weeks and ≥10 cm after 20 weeks 
* Impaired Dopplers include AEDF, REDF, AFDV, RFDV and PUVF 
Although the vascular anastomoses are an anatomical prerequisite, the pathogenesis of 
TTTS must be more complex than a simple net transfer of red blood cells, because both 
twins usually have similar hemoglobin values (Saunders et al., 1999). As mentioned above, 
TTTS is a problem of amniotic fluid discordance with a volume-overloaded recipient and a 
volume-depleted donor and not a problem of hemoglobin discordance with a polycythemic 
recipient and anemic donor. Therefore, endocrine factors related to fluid and pressure 
homeostasis are likely to be involved as well. Due to the intertwin blood exchange, one twin 
is exposed to the endocrine environment of the other. As such, transfer of renin-angiotensin-
aldosterone effectors from the donor may partly explain the recipient’s hypertensive 
cardiomyopathy and volume overload (Mahieu-Caputo et al., 2005). 
1.3.2  Management 
The natural history of TTTS is variable. Although not all cases of TTTS may show 
progressive deterioration, time-related changes may occur if the disease is managed 
expectantly or symptomatically. The natural history of stage I TTTS is that > 75% of cases 
remain stable or regress without invasive intervention and with good perinatal outcome.  In 
contrast, the natural history of stages III and IV TTTS is bleak, with perinatal loss rate of 
70-100%, particularly when it presents before 26 weeks (SMFM clinical guideline 2013; 
Hecher et al., 2000). 
Stage Polyhydramnios* /  Oligohydramnios
Absent bladder 
in donor
Impaired 
Dopplers* Hydrops
Intrauterine 
demise
I + - - - -
II + + - - -
III + + + - -
IV + + + + -
V + + + + +
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Several studies have shown that in severe TTTS presenting before 26 weeks, endoscopic 
laser coagulation of the chorionic-plate-communicating vessels results in higher survival 
rates and lower rates of neurologic complications at 6 months of age than serial 
amnioreduction (Table 4; Ville et al., 1992; Ville et al., 1995; Senat et al., 2004; Huber et al., 
2006; Rossi et al., 2008). Serial amnioreductions are associated with mortality rates up to 
60%, a median gestational age at delivery around 28 weeks and up to 50% severe 
neurodevelopmental impairment in survivors (Roberts et al., 2008) 
Table 4. Laser therapy and serial amnioreduction as treatment for twin-twin transfusion syndrome 
(Rossi et al., 2008). 
Endoscopic laser coagulation involves photocoagulating the vascular anastomoses crossing 
from one side of the placenta to the other.  The goal of laser ablation is to functionally 
separate the placenta into 2 regions, each supplying one of the twins. Disease recurrence 
after fetoscopic laser is attributable to residual anastomoses. The reported rate of residual 
anastomoses in several studies varies from 4% to 33%, depending on the used technique 
(Zhao et al., 2014). Residual anastomoses lead to chronic inter-twin transfusion and 
insufficient compensation. Large unidirectional residual channels are more likely to cause 
TTTS, whereas small vessels less than 1 mm located within 2 cm of the placental edge 
have been specifically implicated in post-laser TAPS (Baschat et al., 2013).  
The recommended technique is a selective coagulation of the anastomoses at the vascular 
equator combined with additional coagulation of the area between the selectively 
Outcome Laser % Amnioreduction %
Overall survivors 57-77 38-81
At least 1 survivor 75-87 9-49
Neonatal death 4-12 14-39
Cerebral injury 2-33 18-83
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coagulated anastomoses, known as ‘Solomon technique’ or equatorial laser dichorionisation 
of the placenta (Figure 7). 
 
Figure 7. Schematic representation of laser techniques (left; Reprinted from Baschat et al., 2013) and 
TTTS placenta treated with laser using the Solomon technique (right; Reprinted from Slaghekke et 
al., 2014). 
The Solomon technique significantly reduces the incidence of TAPS and recurrent TTTS 
and may improve survival and neonatal outcome, without identifiable adverse outcome or 
complications (Table 5; Slaghekke et al., 2016; Ruano et al., 2013; Baschat et al., 2013).  
Table 5. Comparison between the two techniques for laser coagulation of the communicating 
intertwin vascular anastomosis (Slaghekke et al., 2016). 
Outcome Solomon technique (%) Selective technique (%)
TAPS 0 - 2.9 4.2 - 15.6
Recurrent TTTS 0 - 3.9 5.3 - 8.5
Dual survival 64 – 85 46 – 76
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1.3.3 Outcome after laser surgery 
In a combined data in 34 studies on a total of 3,868 pregnancies complicated by TTTS 
treated with fetoscopic laser coagulation the mean perinatal survival of both twins was 52% 
(±14.8), one twin was 29% (±10.5) and at least one twin was 81% (±8.3). The overall 
survival of fetuses was 5,348/7,736 (69%). However, the meta-analysis did not show 
detailed data about stage related survival (Akkermans et al., 2015). 
I performed a literature search to identify all articles in English, which reported Quintero-
stage related outcomes and the results are summarised in Tables 6-8. In total, there were 
1641 cases of TTTS with or without coexistent IUGR treated with endoscopic laser 
coagulation of the chorionic-plate-communicating vessels. There were 244 cases with stage 
I TTTS, 480 cases with stage II TTTS, 784 cases stage III TTTS and 153 cases stage IV 
TTTS. 
• In stage I, overall survival rate was 85%, at least one survival was 92%, and two 
survivors were present in 78%. 
• In stage II, overall survival rate was 77%, at least one survival was 87%, and two 
survivors were present in 66%. 
• In stage III, overall survival rate was 69%, at least one survival was in 83%, and two 
survivors were present in 49%. 
• In stage IV, overall survival rate was 69%, at least one survival was in 83%, and two 
survivors were present in 55%. 
In cases of severe TTTS, combining stage III and IV, overall survival rate was 69%, at 
least one survival was in 83%, and two survivors were present in 50%. 
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Table 6. Survival in stage I TTTS treated by endoscopic laser coagulation. 
Table 7. Survival in stage II TTTS treated by endoscopic laser coagulation. 
*Reported median gestation combined for all TTTS stages 
  Study n Laser weeks
Survival of babies Delivery 
weeksOverall (%) ≥ 1 (%) Both (%)
Quintero et al., 2003 21 20 (16-25)* 32 (76.2) 18 (85.7) 14 (66.7) 32 (16-40)*
Huber et al., 2006 29 22 (17-25) 49 (84.5) 27 (93.1) 22 (75.9) 32 (25-38)
Middeldorp et al., 2007 10 20 (16-26)* 19 (95.0) 10 (100) 9 (90.0) 33 (18-40)*
Chmait et al., 2011 112 21 (16-26) 191 (85.3) 103 (91.9) 88 (78.6) 33 (20-40)
Müllers et al., 2015 9 20 (16-25)* 14 (77.8) 8 (88.9) 6 (66.7) 32 (24-40)*
Emery et al., 2015 45 21.1 ± 2.1 78 (86.7) 42 (93.3) 36 (80.0) 31.9 ± 4.4
Chang et al., 2016 18 21.3 ± 2.4 31 (86.1) 17 (94.4) 14 (77.8) 33.7 ± 4.7
Total 244 414 (84.8) 225 (92.2) 189 (77.5)
 Study n Laser weeks
Survival of babies Delivery 
weeksOverall (%) ≥ 1 (%) Both (%)
Quintero et al., 2003 35 20 (16-25)* 47(67.1) 29 (82.9) 16 (45.7) 32 (16-40)*
Gray et al., 2006 5 21 (19-23)* 3 (30.0) 2 (40.0) 1 (20.0) 34 (29-36)*
Huber et al., 2006 81 21 (16-24) 116 (71.6) 67 (82.7) 49 (60.5) 34 (23-40)
Middeldorp et al., 2007 42 20 (16-26)* 64 (76.2) 35 (83.3) 29 (69.0) 33 (18-40)*
Sepulveda et al., 2007 9 22 (20-25) 11 (61.1) 7 (77.8) 4 (44.4) 31 (25-36)
Morris et al., 2010 8 19 (19-20) 11 (68.8) 8 (100) 3 (37.5) 34 (31-35)
Chmait et al., 2011 177 20 (16-27) 300 (84.7) 165 (93.2) 135 (76.3) 33 (19-38)
Ruano et al., 2013 50 20 (15-26)* 77 (77.0) 45 (90.0) 32 (64.0) 31 (16-39)*
Müllers et al., 2015 42 20 (16-25)* 55 (65.5) 32 (76.2) 23 (54.8) 32 (24-40)*
Chang et al., 2016 29 20.6 ± 2.7 48 (82.8) 25 (86.2) 23 (79.3) 32.4 ± 5.8
Thia et al., 2016 2 19 (19-20) 3 (75.0) 2 (100) 1 (50.0) 31 (28-34)
Total 480 735 (76.6) 417 (86.9) 316 (65.8)
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Table 8. Survival in stage III and stage IV TTTS treated by endoscopic laser coagulation.  
*Reported median gestation combined for all TTTS stages 
Study n Laser weeks
Survival of babies Delivery 
weeksOverall (%) ≥ 1 (%) Both (%)
Stage III
Quintero et al., 2003 28 20 (16-25)* 29 (51.7) 22 (78.6) 7 (25.0) 32 (16-40)*
Gray et al., 2006 17 21 (19-23)* 28 (82.4) 16 (94.1) 12 (70.6) 34 (29-36)*
Huber et al., 2006 80 19 (15-25) 109 (68.1) 66 (82.5) 43 (53.6) 34 (27-40) 
Middeldorp et al., 2007 41 20 (16-26)* 57 (69.5) 33 (80.5) 24 (58.3) 33 (18-40)*
Sepulveda et al., 2007 21 20 (17-24) 20 (47.6) 16 (76.2) 4 (19.0) 31 (23-38)
Morris et al., 2010 129 20 (18-22) 165 (64.0) 113 (87.6) 52 (40.3) 33 (30-34)
Chmait et al., 2011 328 19 (15-27) 482 (73.4) 290 (88.4) 192 (58.5) 33 (17-39)
Ruano et al., 2013 47 20 (15-26)* 53 (56.4) 32 (68.1) 21 (44.7) 31 (16-39)*
Müllers et al., 2015 50 20 (16-25)* 88 (88.0) 34 (68.0) 18 (36.0) 32 (24-40)*
Chang et al., 2016 40 20.2 ± 2.7 53 (66.3) 30 (75.0) 13 (32.5) 29.7 ± 5.6
Thia et al., 2016 3 21 (19-21) 3 (50.0) 2 (66.7) 1 (33.3) 29 (27-30)
Total 784 1087 (69.3) 654 (83.4) 387 (49.4)
Stage IV
Quintero et al., 2003 11 20 (16-25)* 14 (63.6) 9 (81.8) 5 (45.5) 32 (16-40)*
Gray et al., 2006 9 21 (19-23)* 17 (94.4) 9 (100) 8 (88.9) 34 (29-36)*
Huber et al., 2006 10 20 (18-22) 12 (60.0) 7 (70.0) 5 (50.0) 32 (26-36) 
Middeldorp et al., 2007 7 20 (16-26)* 7 (50.0) 4 (57.1) 3 (42.9) 33 (18-40)*
Sepulveda et al., 2007 3 22 (19-25) 3 (50.0) 2 (66.7) 1 (33.3) 32 (31-33)
Morriset al., 2010 27 20 (17-21) 26 (48.1) 18 (66.7) 8 (29.6) 31 (27-35)
Chmait et al., 2011 63 21 (16-26) 101 (80.2) 58 (92.1) 43 (68.3) 33 (20-39)
Ruano et al., 2013 5 20 (15-26)* 9 (90.0) 5 (50.0) 4 (80.0) 31 (16-39)*
Müllers et al., 2015 5 20 (16-25)* 7 (70.0) 5 (100) 2 (40.0) 32 (24-40)*
Changet al., 2016 13 21.3 ± 3.3 15 (57.7) 10 (76.9) 5 (38.5) 30.2 ± 6.6
Total 153 211 (69.0) 127 (83.0) 84 (54.9)
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1.3.4. Long-term neurodevelopmental outcome for TTTS 
TTTS is associated with an increased risk of neonatal mortality and morbidity, including 
severe cerebral injury. Twins treated with amnioreduction are less likely to survive, 
compared to twins treated with laser surgery.  
The incidence of long-term neurodevelopmental impairment (NDI) in TTTS treated with 
amnioreduction is high, on average 20%. The long-term outcome in TTTS treated with laser 
is more favorable; NDI is reported in 10% of cases. This significant difference in outcome is 
partly due to the higher rate of severe prematurity in TTTS treated with amnioreduction.  
The association between low gestational age at birth and NDI is not surprising, as 
prematurity is a well-recognised risk factor for adverse neurodevelopmental outcome. Other 
important risk factors are advanced gestational age at intervention, higher Quintero stage, 
severe cerebral injury, low birth weight, and low parental educational level (Van Klink et al., 
2016).  
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 1.4 SELECTIVE FETAL GROWTH RESTRICTION  
1.4.1 Classification  
The definition of sFGR in monochorionic twins is not universally established. Previous 
studies have used variable criteria including estimated fetal weight of the small twin < 5th or 
< 10th centile, (Sebire et al., 1997; Quintero et al., 2001; Gratacos et al., 2004; Chauhan et 
al., 2004), abdominal circumference (Vanderheyden et al., 2005) and/or the degree of fetal 
weight discordance of 25% (Sebire et al., 1997; Gratacos et al., 2004; Chauhan et al., 2004; 
Victoria et al., 2001). Selective FGR, defined by the estimated fetal weight of the small twin < 
5th and the presence of a > 25% discordance in estimated weight between the fetuses, is 
observed in 12% of MCDA twins (Sebire et al., 1997).  
One parameter, which best reflects the differences in sFGR in MC pregnancies with respect 
to singletons or dichorionic twins is umbilical artery (UA) Doppler flow. The characteristics of 
UA Doppler flow may be strongly influenced by the existence of intertwin vascular 
connections. The condition is subdivided into types I, II and III according to the Dopp ler 
finding of the end diastolic flow in the umbilical artery of the small fetus, which is positive in 
type I, absent or reversed (AREDF) in type II or intermittent AREDF (iAREDF) in type III 
(Figure 8; Gratacos et al., 2007). 
 
Figure 8. Doppler examination of umbilical artery in sFGR with positive EDF (left), absent EDF 
(middle) and intermittent AREDF (right) (Reprinted from FMF and Gratacos et al., 2009). 
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1.4.2  Management 
In type I sFGR expectant management with close monitoring to define the best time of 
delivery is associated with good perinatal outcome for both twins (Table 9). In the combined 
data from four studies on a total of 115 such pregnancies 97% of small and big babies 
survived. 
Table 9. Reports on outcome of MC twin pregnancies with type I sFGR managed expectantly. 
* No associated TTTS 
In type II sFGR without TTTS management options include close monitoring and early 
delivery if there is evidence of deterioration of the small fetus, endoscopic laser ablation of 
placental vascular communications between the two fetuses and cord occlusion of the FGR 
twin either in all cases or in those with evidence of deterioration at an early gestational age. 
In type II sFGR with superimposed TTTS the preferred management is endoscopic laser.  
Table 10 summarises the data of studies on different management strategies of sFGR with or 
without coexistent TTTS.  
Study n Definition sFGR*
Survival of babies (%) Delivery 
weeksSmall Large
Gratacos et al., 2004 22 Small <5th, 25%discordance 22 (100) 22 (100) 29 (24-35)
Gratacos et al., 2007 39 Small <10th 38 (97.4) 38 (97.4) 35 (16-38)
Ishii et al., 2009 23 Small <10th 22 (95.7) 22 (95.7) 36 (26-38)
Ishii et al., 2011 31 Small <10th, Large >10th 30 (96.8) 30 (96.8) 29 (26-38)
Total 115 112 (97.4) 112 (97.4)
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Table 10. Reports on management of MC twin pregnancies with type II sFGR. 
In a combined data in five studies in type II sFGR without TTTS managed expectantly on a 
total of 127 pregnancies, 53% of small and 75% of big babies survived.  
Study n Definition of sFGR
Survival of babies (%) Delivery 
weeks
Small Large
Expectant
Quintero et al., 2001 12 Small <10th, 25% discordance 6 (50.0) 9 (75.0) 30 (26-39)
Huber et al., 2006 19 Small <5th 10 (52.6) 13 (68.4) 32 (26-36)
Ishii et al., 2009 27 Small <10th 10 (37.0) 18 (66.7) 28 (18-40)
Ishii et al., 2011 55 Small <10th 27 (49.1) 41 (74.5) 32 (18-40)
Visentin et al., 2013 14 Small <10th 14 (100) 14 (100) 30 (28-34)
Total 127 67 (52.8) 95 (74.8)
Laser surgery
- No TTTS
Quintero et al., 2001 8 Small <10th 3 (37.5) 4 (50.0) 31 (25-34)
Chalouhi et al., 2013 23 Small <5th, 25% discordance 7 (30.4) 17 (73.9) 33 (31-34)
Total 31 10 (32.3) 21 (67.7)
- TTTS
Chalouhi et al., 2013 166 Small <5th, 25% discordance 69 (41.6) 92 (55.4) 33 (32-34)
Cord occlusion
- In all cases
Bebbington et al., 2012 24 Small <10th, 25% discordance 0 21 (87.5) -
Chalouhi et al., 2013 22 Small <5th, 25% discordance 0 20 (90.9) 31 (29-34)
Total 46 0 41 (89.1)
- In 9 / 30 cases
Gratacos et al., 2007 30 Small <10th 21 (70.0) 30 (100) 31 (27-40)
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Two studies reported on endoscopic laser ablation of placental vascular communications in 
type II sFGR without TTTS; in the combined total of 31 pregnancies, 32% of small and 68% 
of big babies survived (Quintero et al., 2001; Chalouhi et al., 2013). One study reported on 
endoscopic laser ablation of placental vascular communications in type II sFGR with TTTS; 
in the total of 166 pregnancies, 42% of small and 55% of big babies survived (Chalouhi et 
al., 2013).  
Elective cord occlusion of the small fetus in type II sFGR without TTTS was reported in two 
studies; in the combined total of 46 pregnancies, 89% of the big babies survived (Bebbington 
et al., 2012; Chalouhi et al., 2013). Another study reported on the expectant management of 
30 cases of type II sFGR without TTTS, but in 9 cases there was early deterioration in the 
condition of the small fetus and cord occlusion was then undertaken; in the 30 cases 70% of 
small and 100% of big babies survived (Gratacos et al., 2007).   
In type III sFGR there is a high risk of perinatal death and handicap for both twins. In this 
condition the close proximity of the umbilical cords precludes the option of endoscopic laser 
surgery. In a combined series of 142 pregnancies that were managed expectantly the small 
baby survived in 79% of cases and the big baby survived in 89% of cases (Table 11). 
Table 11. Outcome of MC twin pregnancies with type III sFGR without superimposed TTTS 
managed expectantly. 
Study n Definition of sFGR
Survival of babies (%) Delivery 
weeksSmall Large
Gratacos et al., 2004 18 Small <10th, 25% discordance 13 (72.2) 16 (88.9)
Gratacos et al., 2007 65 Small <10th 51 (78.4) 61 (93.8) 32 (23-39)
Gratacos et al., 2008 31 Small <10th 25 (80.6) 28 (90.3) 33 (23-38)
Ishii et al., 2010 13 Small <10th 11 (84.6) 10 (76.9) 31(25-37)
Ishii et al., 2011 15 Small <10th 12 (80.0) 11 (73.3) 31(25-37)
Total 142 112 (78.9) 126 (88.7)
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1.5 MANAGEMENT OF TRIPLET PREGNANCIES DIAGNOSED IN THE FIRST 
TRIMESTER 
1.5.1 Incidence of triplet pregnancies  
The prevalence of spontaneous triplet pregnancy is about one in 7000 deliveries, but with the 
increasing availability of assisted reproductive technologies, particularly in vitro fertilisation 
and controlled ovarian hyperstimulation, the rate of triplet and other higher-order multiple 
pregnancies has risen dramatically in the last 2 decades.  
Although most triplet pregnancies resulting from assisted reproductive techniques are 
trizygotic and therefore trichorionic, the rate of monozygosity is two to three times higher in 
assisted conceptions compared with spontaneous pregnancies (Sepulveda et al., 1996; 
Edwards et al., 1986). The rate of monozygotic triplet pregnancies in a triplet population is 
estimated as 4.5%, but the exact fraction of monochorionic triplets remains unknown (De 
Catte et al., 2000). Although multiple births have increased and most of the reported 
monochorionic triplet pregnancies have been conceived by in-vitro-fertilisation, the 
monochorionic triplet pregnancy is rare, and is estimated to be approximately 1 in 100,000 
births (Ghulmiyyah et al., 2003; Ulug et al., 2004) 
1.5.2 Consequences of expectant management and embryo reduction 
In triplet pregnancies diagnosed during the first trimester management options include 
continuing with the whole pregnancy or embryo reduction (ER) to twins or singletons. 
In trichorionic triplets (TCT), ER is achieved by fetal intracardiac injection of potassium 
chloride (KCl). The beneficial consequence of ER is the decrease in the rate of early preterm 
birth (PTB), but at the expense of increased rate of miscarriage. Table 12 summarises the 
results of studies reporting on the management of TCT pregnancies with three live fetuses at 
8-14 weeks’ gestation. In the combined data from these studies the rates of miscarriage at 
<24 weeks’ gestation were 4.2% for expectant management, 7.4% for ER to twins and 
!51
INTRODUCTION 
!  
10.3% for ER to singleton. The respective rates for preterm birth at <33 weeks were 35.1%, 
13.1% and 8.0%.  
Table 12. Studies reporting on the management of TCT pregnancies.  
Study n Miscarriage (%)
Preterm birth (%)
<32w <33w <34w
Expectant management
Antsaklis et al., 2004 70 2 (2.9) 25/68 (36.8)
Skiadas et al., 2011 59 0 (0.0) 36/59 (61.0)
Chaveeva et al., 2013 229 9 (3.9) 76/220 (34.5) 109/220 (49.5)
Drugan et al., 2013 36 2 (5.6) 13/34 (38.2)
Shiva et al., 2014 58 6 (12.1) 16/52 (30.8)
Total 452 19 (4.2) 29/86 (33.7) 101/288 (35.1) 145/279 (52.0)
Embryo reduction to 2
Antsaklis et al., 2004 185 15 (8.1) 19/170 (11.2)
Athanasiadis et al., 2005 160 12 (7.5)
Skiadas et al., 2011 87 6 (6.9) 16/81 (19.8)
Kuhn-Beck et al., 2012 136 7 (5.1) 16/128 (12.4)
Chaveeva et al., 2013 265 21 (7.9) 36/244 (14.8) 51/244 (20.9)
Drugan et al., 2013 46 3 (6.5) 3/34 (8.8)
Haas et al., 2014 55 2 (3.6) 0/53 (0.0) 4/53 (7.5)
Shiva et al., 2014 57 7 (12.3) 6/50 (12.0)
Total 991 73/991 (7.4) 9/137 (6.6) 71/542 (13.1) 71/378 (18.8)
Embryo reduction to 1
Kuhn-Beck et al., 2012 44 4 (9.1) 4/40 (10.0)
Chaveeva et al., 2013 34 5 (14.7) 2/29 (6.9) 3/29 (10.3)
Haas et al., 2014 19 1 (5.3) 1/18 (5.6) 1/18 (5.6) 1/18 (5.6)
Total 97 10 (10.3) 1/18 (5.6) 7/87 (8.0) 4/47 (8.5)
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In dichorionic triplet (DCT) pregnancies, ER by intracardiac injection of KCl involves either 
the dichorionic fetus or both monochorionic twins; the injected KCl to only one of the 
monochorionic twins could be transferred to the co-twin through the inter-twin placental 
vascular anastomoses or death of one fetus could lead to hemorrhage from the co-twin 
into the dead feto-placental unit with consequent death or neurodevelopmental 
impairment in the survivor. Table 13 summarises the results of studies reporting on the 
management of DCT pregnancies with three live fetuses at 8-14 weeks’ gestation. In DCT 
pregnancies, compared to TCTs, there is a higher rate of miscarriage both with expectant 
management and after ER to twins, which could, at least in part, be attributed to 
complications arising from inter-twin placental vascular communications and / or unequal 
sharing of the placenta in the monochorionic pair. 
Table 13. Studies reporting on the management of DCT pregnancies. 
Study n Miscarriage (%)
Preterm birth (%)
<32w <33w <34w
Expectant management
Skiadas et al., 2010 13 2 (15.4) 5/11 (45.5)
Chaveeva et al., 2013 123 10 (8.1) 52/113 (46.0) 78/113 (69.0)
Morlando et al., 2015 77 7 (9.1) 17/70 (24.3) 70/70 (100)
Abel et al., 2016 16 1 (6.3) 14/15 (93.3)
Van de Mheen et al., 2016 42 4 (9.5) 17/38 (44.7)
Total 271 24 (8.9) 69/183 (37.7) 167/209 (79.9)
Embryo reduction to 2
Chaveeva et al., 2013 15 2 (13.3) 3/13 (23.1) 4/13 (30.8)
Embryo reduction to 1
Skiadas et al., 2010 13 3 (23.1) 1/10 (10.0)
Chaveeva et al., 2013 29 4 (13.8) 2/25 (8.0) 2/25 (8.0)
Morlando et al., 2015 10 2 (20.0) 1/8 (12.5) 8/8 (100)
Abel et al., 2016 30 6 (20.0) 1/24 (4.2)
Total 82 15 (18.3) 3/33 (9.1) 12/67 (17.9)
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1.5.3 Intrafetal laser for embryo reduction of dichorionic triplets to dichorionic twins  
A recent study has proposed a new approach for ER of DCT pregnancies to dichorionic 
twins by ultrasound-guided laser ablation of the pelvic vessels of one of the monochorionic 
twins (Chaveeva et al., 2014). In a series of 22 DCT pregnancies undergoing intrafetal 
laser ultrasound examination within two weeks of the procedure demonstrated that the co-
twin had died in 11 cases and was alive in the other 11; in the dichorionic group there was 
one miscarriage at 23 weeks and in the other 10 cases there were two live births at a 
median gestational age of 35 weeks, whereas in the 11 cases where both monochorionic 
fetuses died the separate triplet was live born at a median gestation of 38 weeks. 
One other study has reported on the outcome of a series of DCT pregnancies managed 
by occlusion of the blood supply to one of the monochorionic pair (Morlando et al., 2015). 
In this multicenter study ultrasound guided laser or radiofrequency ablation of pelvic 
vessels was carried out in 12 DCT pregnancies at 10-14 weeks’ gestation. Two (17%) 
pregnancies miscarried and in the remaining 10 there were two survivors in seven and 
one survivor in three; PTB at <33 weeks occurred in 40% (4 of 10) of cases. 
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1.6 OBJECTIVES 
The aims of this thesis are: 
• To examine the outcome of monochorionic diamniotic twins with selective fetal growth 
restriction type II, with or without coexistent twin-to-twin transfusion syndrome, treated 
by endoscopic placental laser coagulation and to determine predictors of survival of the 
growth restricted and appropriately grown for gestational age twins.  
• To report outcome of monochorionic and dichorionic triamniotic triplet pregnancies 
treated with endoscopic laser coagulation of communicating placental vessels for 
severe feto-fetal transfusion syndrome and selective fetal growth restriction.  
• To report the outcome of dichorionic triplet pregnancies reduced to dichorionic twins 
by laser ablation of the pelvic vessels of one of the monochorionic twins.  
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STUDY 1 
Peeva G, Bower S, Orosz L, Chaveeva P, Akolekar R, Nicolaides KH: Endoscopic placental 
laser coagulation in monochorionic diamniotic twins with type II selective fetal growth 
restriction. Fetal Diagn Ther 2015; 38: 86-93.  
Selective fetal growth restriction, defined by the presence of a ≥ 25% discordance in 
estimated weight between the fetuses, is observed in 12% of monochorionic diamniotic twin 
pregnancies. The condition is subdivided into types I, II and III according to the Doppler 
finding of the end diastolic flow in the umbilical artery of the small fetus, which is normal in 
type I, absent or reversed (AREDF) in type II or intermittent AREDF in type III. Some cases of 
sFGR are complicated by twin-to-twin transfusion syndrome, defined by marked 
discordance in amniotic fluid volume with deepest vertical pool of ≤2 cm in one sac and ≥ 
8 cm before 20 weeks and > 10 cm after 20 weeks in the other sac. In TTTS the severity 
of the disease is classified as stage I if the Doppler findings in the umbilical artery and 
ductus venosus of both fetuses are normal and the bladder of the donor is visible, stage II 
with normal Doppler findings but not visible bladder, stage III with abnormal Doppler 
findings in either twin and stage IV with presence of ascites or hydrops in either twin. 
This study reports our experience with endoscopic laser surgery in MCDA twins with sFGR 
type II, with or without coexistent TTTS, and investigates predictors of survival of the growth 
restricted and appropriately grown for gestational age. 
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STUDY 2 
Peeva G, Chaveeva P, Gil Guevara E, Akolekar R, Nicolaides KH: Endoscopic placental 
laser coagulation in dichorionic and monochorionic triplet pregnancies. Fetal Diagn Ther 
2016; 40: 174-180. 
Monochorionic pregnancies are often complicated by severe feto-fetal transfusion 
syndrome (FFTS) and / or selective fetal growth restriction. The established treatment of 
choice in the management of severe FFTS or some cases of sFGR in MC twin 
pregnancies is endoscopic laser coagulation of the inter-twin communicating placental 
vessels. Few studies in a small number of patients have reported on endoscopic laser 
coagulation of communicating placental vessels for the management of FFTS in MC or 
dichorionic triamniotic (TA) triplet pregnancies complicated by FFTS.  
This study reports our experience with endoscopic laser surgery in the management of 
severe FFTS or sFGR in MC and DC triplet pregnancies and compares the results with 
those of previous studies. 
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STUDY 3  
Chaveeva P, Peeva G, Gil Pugliese S, Shterev A, Nicolaides KH: Intrafetal laser for embryo 
reduction from dichorionic triplets to dichorionic twins. Ultrasound Obstet Gynecol 2017; Aug 
9. doi: 10.1002/uog.18834. 
In dichorionic triplet pregnancies diagnosed during the first trimester there is a high risk of 
miscarriage and early preterm birth at <33 weeks’ gestation. Management options include 
continuing with the whole pregnancy or embryo reduction by intracardiac injection of KCl into 
the dichorionic fetus or both monochorionic twins. Previous studies reported that with 
expectant management the rates of miscarriage and PTB are 9% and 38%, respectively. The 
rates after ER to twins are 13% and 23% and after ER to singleton are 18% and 9%. 
This study examines the outcome of 60 DCT pregnancies undergoing ER to dichorionic twins 
using a new method of ultrasound-guided laser ablation of the pelvic vessels of one of the 
monochorionic twins. 
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 Introduction 
 Selective fetal growth restriction (sFGR), defined by 
the presence of a  ≥ 25% discordance in estimated weight 
between the fetuses, is observed in 12% of monochori-
onic diamniotic (MCDA) twin pregnancies  [1] . The con-
dition is subdivided into types I, II and III according to 
the Doppler finding of the end diastolic flow (EDF) in the 
umbilical artery of the small fetus, which is normal in type 
I, absent or reversed (AREDF) in type II or intermittent 
AREDF in type III  [2] . Some cases of sFGR are compli-
cated by twin-to-twin transfusion syndrome (TTTS), de-
fined by marked discordance in amniotic fluid volume 
with the deepest vertical pool of  ≤ 2 cm in one sac and  ≥ 8 
cm before 20 weeks and >10 cm after 20 weeks in the 
other sac  [3, 4] . In TTTS, the severity of the disease is clas-
sified as stage I if the Doppler findings in the umbilical 
artery and ductus venosus of both fetuses are normal and 
the bladder of the donor is visible, stage II with normal 
Doppler findings but not visible bladder, stage III with 
abnormal Doppler findings in either twin and stage IV 
with presence of ascites or hydrops in either twin  [3] .
 In the management of TTTS, endoscopic laser coagu-
lation of the inter-twin communicating placental vessels 
 Key Words 
 Monochorionic twins · Selective fetal growth restriction · 
Twin-to-twin transfusion syndrome · Endoscopic laser 
coagulation 
 Abstract 
 Objective: To determine predictors of survival in monocho-
rionic diamniotic twins with selective fetal growth restriction 
type II (sFGR-II), with or without twin-to-twin transfusion 
syndrome (TTTS), treated by endoscopic placental laser co-
agulation.  Methods: Laser surgery was performed at 20 (15–
27) weeks’ gestation in 405 cases of sFGR-II with a
without coexisting TTTS. Multivariable logistic regression
analysis was performed to determine significant predictors
of survival to discharge from hospital.  Results: There was
survival of the small twin in 216 (39.5%) and of the large twin 
in 379 (69.3%) cases. Significant predictors of survival of both 
the small and larger twin were ductus venosus Doppler find-
ings in the small twin, gestational age at laser and cervical
length, but not the presence of TTTS or Doppler findings in 
the large twin.  Conclusions: In sFGR-II, survival after laser
surgery is primarily dependent on the condition of the small 
twin.  © 2015 S. Karger AG, Basel 
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is the established treatment of choice  [4–6] . In type I 
sFGR without TTTS, expectant management with close 
monitoring to define the best time of delivery is associ-
ated with good perinatal outcome for both twins  [2, 7] . In 
types II and III sFGR without TTTS, there is a high risk 
of perinatal death and handicap for both twins; the best 
management, which includes early delivery, cord occlu-
sion of the FGR twin or endoscopic laser surgery, is un-
certain because of the small number of reported cases  [2, 
7–11] . 
 The objectives of this study are to, firstly, examine the 
outcome of MCDA twins with sFGR type II, with or with-
out coexistent TTTS, treated by endoscopic placental la-
ser coagulation and, secondly, determine predictors of 
survival of the growth-restricted and appropriately grown 
for gestational age twins.
 Patients and Methods 
 This study comprised all cases of MCDA twins complicated by 
sFGR-II, with and without coexisting TTTS, which were treated by 
endoscopic laser coagulation of the inter-twin communicating 
placental vessels in our fetal medicine centre between 1992, when 
we first introduced endoscopic laser surgery  [4] , and April 2014. 
Umbilical cord occlusion was not a treatment option for sFGR or 
TTTS in our centre. In total, there were 556 cases that fulfilled the 
entry criteria, but 9 were excluded from further analysis because 
they were lost to follow-up. The study population comprised 547 
cases of sFGR-II, including 405 (74%) with coexisting TTTS and 
142 (26%) without TTTS. The TTTS was stage III in 385 (95%) 
cases and stage IV in 20 (5%).
 Gestational age was determined by ultrasound measurements 
of the larger twin, including crown-rump length at <14 weeks  [12] 
and head circumference at  ≥ 14 weeks  [13] . Diagnosis of sFGR was 
based on the demonstration that, firstly, the abdominal circumfer-
ence at <22 weeks or estimated fetal weight at  ≥ 22 weeks was below 
the 5th percentile of the appropriate reference range  [13–15] and, 
secondly, the inter-twin discordance in estimated fetal weight 
(weight difference divided by the weight of the large twin) was 
 ≥ 25%. The estimated fetal weight at <20 weeks was derived by the 
formula by Warsof et al.  [16] , and at  ≥ 20 weeks it was derived by 
the formula of Hadlock et al.  [14] .
 Doppler assessment of the umbilical arteries of both twins and 
classification of the EDF as normal, absent or reversed was carried 
out in all cases. Doppler assessment of the fetal ductus venosus and 
classification of the a-wave as positive, negative or reversed was 
systematically carried out only after 1995  [17] . 
 Endoscopic laser surgery was carried out using a semi-rigid 2.0-
mm diameter fetoscope (Karl Storz GmbH, Tuttlingen, Germany) 
through a 3.3-mm diameter cannula (Cook Medical, Blooming-
 Table 1.  Pregnancy characteristics in monochorionic twin pregnancies with sFGR-II following treatment with endoscopic laser surgery 
in fetuses that survived and those that did not survive
 Characteristic Smaller fetus Larger fetus
alive (n = 216) dead (n = 331) al ive (n = 379) dead (n = 168)
32.1 (28.1–38.3)* 35.4 (29.9 – 42.4) 33.8 (28.7 – 41.6) 34.5 (30.0 – 39.7)Discordance
Coexisting twin-to-twin transfusion
Yes 161 (74.5) 244 (73.7) 283 (74.7) 122 (72.6)
55 (25.5) 87 (26.3) 96 (25.3) 46 (27.4)No
Umbilical artery end diastolic flow
– – 340 (89.7) 146 (86.9)
202 (93.5) 282 (85.2) 37 (9.8) 21 (12.5)
Positive
Negative
Reversed 14 (6.5)* 49 (14.8) 2 (0.5) 1 (0.6)
Ductus venosus a-wave (n = 516)
Positive 165 (80.5%) 170 (54.7%) 277 (76.9%) 116 (74.4%)
40 (19.5%)* 141 (45.3%) 83 (23.1%) 40 (25.6%)
15 (10 – 19)* 14 (8 – 18) 15 (10 – 18)* 13 (7 – 18)
Negative/reversed
Year of laser – 1992
Placental position
108 (50.0) 165 (49.8) 190 (50.1) 83 (49.4)Anterior
Posterior 108 (50.0) 166 (50.2) 189 (49.9) 85 (50.6)
20.4 (18.3 – 23.1)* 19.7 (17.6 – 22.0) 20.1 (18.0 – 22.7) 19.7 (17.6 – 21.9)
31 (27 – 36)* 30 (25 – 34) 31 (27 – 35)* 29 (22 – 35)
32.0 (29.8 – 34.2)* 21.7 (19.1 – 25.0) 32.1 (29.9 – 34.6)* 22.2 (19.8 – 25.4)
Gestation at laser, weeks
Cervical length, mm
Gestation at outcome, weeks
Birth weight, g 1,200 (860 – 1,710) – 1,674 (1,287 – 2,100) –
 Values are presented as median (interquartile range) or n (%). * p < 0.01.
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ton, Ind., USA), which was introduced transabdominally into the 
sac of the larger twin after the administration of prophylactic an-
tibiotics and local anaesthesia. In the cases of sFGR without TTTS, 
we did not undertake amnioinfusion, as previously described  [10] . 
A 400-μm diameter Nd:YAG laser fibre (Dornier Med Tech, 
Wessling, Germany) with a power output of 40 W was used to co-
agulate the inter-twin communicating placental vessels. In the ear-
ly 1990s, all vessels crossing the inter-twin membrane were coagu-
lated  [4, 5] , but from 1999 the technique of selective coagulation 
was adopted  [18] with additional coagulation of the placenta be-
tween the coagulated vessels. Subsequently, in the cases with coex-
isting TTTS, amnioreduction of the polyhydramnios was under-
taken through the cannula over a period of 10–15 min to obtain 
subjective normalisation of the amniotic fluid volume on ultraso-
nographic examination. After a period of rest for 1–3 h, the pa-
tients were discharged home, and follow-up was usually under-
taken in the referral hospitals.
 Maternal demographic characteristics, ultrasound findings 
and details of intrauterine intervention were recorded in a data-
base. Pregnancy outcomes were collected into the same database 
when they became available from the referring hospitals, general 
practitioners or from the patients themselves.
 Statistical Analysis 
 Data from categorical variables were presented as n (%) and 
from continuous variables as median and interquartile ranges. The 
MCDA pregnancies with sFGR were divided into smaller and larg-
er fetuses, and comparisons between the fetuses alive and dead in 
each group were carried out using the χ 2 test or Fisher’s exact test 
for categorical variables and the Mann-Whitney U test for con-
tinuous variables. The tests were considered significant at a p value 
of <0.05 using two-tailed tests.
 Logistic regression analysis was used to determine the variables 
providing a significant contribution in predicting survival of the 
smaller and larger fetuses. In the analysis, discordance in estimat-
ed inter-twin weight was centred at 25%, and experience in laser 
surgery was centred at 1992, when the first procedure was carried 
out. Univariable analysis was carried out to examine the individu-
al variables contributing significantly to the survival of sFGR and 
larger fetuses by assessing their odds ratios and 95% confidence 
intervals. Subsequently, multivariable logistic regression analysis 
with backward stepwise elimination was performed to determine 
which of these variables provided a significant independent con-
tribution in the logistic model. Kaplan-Meier survival analysis was 
used to examine the effect of ductus venosus Doppler of the FGR-
II fetus in determining the proportion of fetuses surviving follow-
ing endoscopic laser surgery. 
 The statistical software package IBM SPSS 21.0 (IBM Corp., 
Armonk, N.Y., USA) was used for data analyses.
 Table 2. Logistic regression analysis for predicting survival of the smaller fetus in monochorionic twin pregnancies with sFGR-II treated 
with endoscopic laser surgery
 Variable Univariable analysis Multivariable analysis
OR 95% CI p value OR 95% CI p value
0.965 0.946 – 0.985 0.001 0.973 0.949 – 0.998 0.032
1.000
1.044 0.705 – 1.545 0.830
Degree of discordance – 25, %
Coexisting twin-to-twin transfusion
No (reference)
Yes
Donor: umbilical artery EDF
1.000 1.000Negative (reference)
Reversed 0.399 0.214 – 0.742 0.004 0.393 0.196 – 0.788 0.009
1.000 1.000
0.292 0.194 – 0.441 <0.0001 0.416 0.265 – 0.653 <0.0001
Donor: ductus venosus a-wave
Positive (reference)
Negative/reversed
Recipient: umbilical artery EDF
1.000Positive (reference)
Negative/reversed 0.993 0.576 – 1.713 0.981
1.000
1.369 0.909 – 2.061 0.133
1.042 1.010 – 1.074 0.008
Recipient: ductus venosus a-wave
Positive (reference)
Negative/reversed
Date of endoscopic laser – 1992
Placental location
1.000Posterior (reference)
Anterior 1.006 0.714 – 1.418 0.972
1.087 1.024 – 1.155 0.006 1.189 1.103 – 1.282 <0.0001Gestational age at laser (weeks)
Cervical length (mm) 1.031 1.008 – 1.055 0.007 1.037 1.012 – 1.063 0.003
OR = Odds ratio; CI = confidence interval.
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 Results 
 The median gestational age at laser surgery was 20 
(range 15–27) weeks for both groups of sFGR-II. In the 
pregnancies with no TTTS (n = 142), there was survival 
of the smaller twin in 55 (38.7%) cases, the larger twin in 
96 (67.6%), at least one twin in 102 (71.8%) and both 
twins in 49 (34.5%) cases; in total, 151 (53.2%) of 284 ba-
bies survived. In the sFGR-II pregnancies with coexisting 
TTTS (n = 405), there was survival of the smaller twin in 
161 (39.7%) cases, the larger twin in 283 (69.8%), at least 
one twin in 291 (71.9%) and both twins in 153 (37.7%) 
cases; in total, 444 (54.8%) of 810 babies survived. The 
median gestational age at delivery for the survivors was 
32 (range 24–41) weeks, and for the intrauterine or post-
natal deaths it was 22 (range 16–37) weeks. Of the 595 
survivors, 63 (10.6%), 211 (35.5%), 281 (47.2%) and 40 
(6.7%) were born at 24–27, 28–31, 32–36 and at  ≥ 37 
weeks’ gestation, respectively. 
 The pregnancy characteristics of the survivors are 
compared with those with intrauterine or neonatal death 
in  table 1 . In the smaller twins that survived, compared to 
those who did not survive, there was significantly lower 
estimated inter-twin weight discordance, prevalence of 
reversed EDF in the umbilical artery and negative or re-
versed a-wave in the ductus venosus, and higher year of 
laser surgery, gestational age at laser, cervical length be-
fore laser and gestational age at delivery. In the larger 
twins that survived, compared to those who did not sur-
vive, there was significantly higher year of laser surgery, 
cervical length before laser and gestational age at delivery. 
 Logistic regression analysis demonstrated that signifi-
cant predictors of the survival of the smaller twin were 
estimated inter-twin weight discordance, Doppler find-
ings in the umbilical artery and ductus venosus of the 
smaller twin, year of endoscopic laser surgery, gestation-
al age at laser and cervical length before laser, but not the 
presence or absence of coexisting TTTS, Doppler find-
ings in the umbilical artery or ductus venosus of the larg-
er twin or placental location ( table 2 ). In the multivariable 
analysis, the significant predictors of survival were esti-
mated inter-twin weight discordance, Doppler findings 
in the umbilical artery and ductus venosus of the smaller 
twin, gestational age at laser and cervical length before 
laser, but not year of endoscopic laser surgery. Multivari-
able logistic regression analysis demonstrated that signif-
  Table 3. Logistic regression analysis for predicting survival of the larger fetus in monochorionic twin pregnancies with sFGR-II treated 
with endoscopic laser surgery
Variable Univariable analysis Multivariable analysis
OR 95% CI p value OR 95% CI p value
0.999 0.979 – 1.019 0.930
1.000
1.112 0.737 – 1.676 0.614
Degree of discordance – 25, %
Coexisting twin-to-twin transfusion
No (reference)
Yes
Donor: umbilical artery EDF
1.000Negative (reference)
Reversed 1.123 0.629 – 2.004 0.695
1.000 1.000
0.487 0.331 – 0.718 <0.0001 0.576 0.377 – 0.880 0.011
Donor: ductus venosus a-wave
Positive (reference)
Negative/reversed
Recipient: umbilical artery EDF
1.000Positive (reference)
Negative/reversed 0.761 0.436 – 1.329 0.337
1.000
0.869 0.562 – 1.343 0.527
1.049 1.017 – 1.082 0.003
Recipient: ductus venosus a-wave
Positive (reference)
Negative/reversed
Date of endoscopic laser – 1992
Placental location
1.000Posterior (reference)
Anterior 1.030 0.716 – 1.481 0.875
1.056 0.990 – 1.127 0.095 1.132 1.050–1.221 0.001Gestational age at laser (weeks)
Cervical length (mm) 1.043 1.019 – 1.068 <0.0001 1.050 1.025 – 1.077 <0.0001
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 Fig. 1. Kaplan-Meier survival curve illustrating the proportion of 
surviving twins in relation to time interval from endoscopic laser 
surgery. The red line is for the larger twin, the black line is for the 
smaller twin and the blue line for both twins. 
icant predictors of the survival of the larger twin were 
Doppler findings in the ductus venosus of the smaller 
twin, gestational age at laser and cervical length before 
laser ( table 3 ). 
 The Kaplan-Meier survival curve illustrating the pro-
portion of surviving twins, irrespective of presence or ab-
sence of coexisting TTTS, in relation to time interval from 
endoscopic laser surgery is shown in  figure 1 . There was 
survival of the smaller twin in 216 (39.5%) cases, the larg-
er twin in 379 (69.3%) and both twins in 201 (36.7%) cas-
es. Most deaths occurred within 2 weeks of laser surgery, 
including 244 (73.7%) of the 331 deaths of the smaller 
twin and 109 (64.9%) of the 168 deaths of the larger twin.
 The survival curves in  figure 2 illustrate the relation 
between the Doppler findings in the ductus venosus of the 
FGR-II twin and the survival of the smaller and larger 
twin. Data on ductus venosus Doppler were available for 
516 pregnancies. The smaller twin died in 170 (51.2%) of 
the 335 cases with positive a-wave and in 141 (77.9%) of 
the 181 cases with negative or reversed a-wave. The larg-
er twin died in 83 (24.7%) of the 335 cases with positive 
a-wave in the ductus venosus of the FGR-II twin a
73 (40.3%) of the 181 with negative or reversed a-wave.
Death of the smaller twin within 2 weeks of endoscopic
laser surgery occurred in 33.4% of cases with positive a-
wave in the ductus venosus of the FGR-II twin and in
 Fig. 2. Kaplan-Meier survival curve demonstrating the effect of 
negative or reversed a-wave in the ductus venosus of the growth-
restricted twin on the proportion of smaller and larger twins sur-
viving after treatment with endoscopic laser surgery. Black lines 
indicate negative or reversed a-wave and red lines indicate positive 
a-wave in ductus venosus. Interrupted lines are for the larger twins 
and solid lines are for the smaller twins. 
50.3% of cases with negative or reversed a-wave (p < 
0.001). The respective values for the larger twin were 12.2 
and 23.8% (p = 0.005).
 Discussion 
 Principal Findings of This Study 
 In about 75% of our cases with sFGR-II, there was co-
existing severe TTTS. This high percentage of coexisting 
TTTS may represent selection bias by referring obstetri-
cians because isolated sFGR has only recently been recog-
nised as a condition for referral to specialist fetal medi-
cine units. In the management of sFGR-II by endoscopic 
laser coagulation of the inter-twin communicating pla-
cental vessels, survival is not related to the presence or 
absence of coexisting TTTS and is observed in about 40% 
of the smaller twins and 69% of the larger twins. There is 
survival of at least one twin in 72% of cases, and in total 
54% of all babies survive.
 Most deaths of both the small and the larger twin occur 
within 2 weeks of laser surgery, and the rate of such death 
is related to the Doppler findings in the ductus venosus 
of the FGR-II twin, gestational age at laser and pre-laser 
cervical length. The rate of death of the smaller and larg-
er twins is 33 and 12% if the a-wave is positive, and the 
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respective rates increase to 53 and 24% if the a-wave is 
negative or reversed. The high mortality rate of the FGR-
II twin within 2 weeks of laser surgery, which is particu-
larly marked in those with abnormal flow in the ductus 
venosus, could at least in part be attributed to the inter-
ruption of the oxygenated blood supply from the larger to 
the smaller twin  [2] . Death of the larger twin, which is also 
related to the degree of cardiovascular compromise of the 
FGR-II twin, could at least in part be the result of miscar-
riage triggered by the intrauterine presence of the dead 
fetoplacental unit of the smaller twin. 
 Limitations of the Study 
 The main limitation of the study is related to the lack of 
data on neonatal morbidity and long-term neurodevelop-
mental outcome. This is mainly because the patients were 
referred for surgery from other centres, often from other 
countries, where the subsequent management of the preg-
nancy and the neonates was undertaken. Nevertheless, 
comparisons can be made with other studies on the basis 
of the gestational age at delivery of the survivors after laser 
surgery, which is the main determinant of prevalence of 
neonatal cerebral lesions  [19] and long-term neurological 
outcome  [20] . Douglas et al. [19] performed neonatal im-
aging in survivors after endoscopic laser surgery and re-
ported severe cerebral lesions in 18.4, 7.3 and 3.7% of those 
born at 24–27, 28–31 and  ≥ 32 weeks’ gestation, respec-
tively. If these figures were applied to our population, the 
estimated rate of neonatal cerebral lesions would be 6.5%.
 Comparison of the Findings with Previous Studies in 
the Literature 
 There is general agreement that the treatment of choice 
for severe TTTS is endoscopic laser coagulation of the 
inter-twin communicating placental vessels. However, 
the best management for sFGR-II without coexistent 
TTTS is uncertain. Gratacos et al. [2] reported that in 
about 90% of cases there is deterioration in the fetal con-
dition with development of abnormal Doppler findings 
in the ductus venosus or abnormal fetal heart rate pat-
terns necessitating early delivery or cord occlusion. Ishii 
et al. [7] described the natural history of the condition in 
a series of 27 pregnancies with FGR-II diagnosed at <26 
weeks’ gestation and managed expectantly. There was fe-
tal or neonatal death of the small twin in 48% of cases and 
of the larger twin in 33%; at 6 months of age, there was 
evidence of neurological damage in 29% of the surviving 
smaller twins and in 17% of the larger twins  [7] . In a study 
of 30 cases of sFGR-II diagnosed at a median gestational 
age of 20 weeks, the intended management was expectant 
but in 9 cases cord occlusion was carried out because of 
deterioration in the condition of the FGR twin; all re-
maining babies survived after delivery at a median gesta-
tion of 30 weeks, but in 14% of the small neonates there 
was evidence of brain damage  [2] .
 The alternative options in the management of sFGR-II 
are elective cord occlusion of the FGR twin or endoscop-
ic laser coagulation of the inter-twin communicating pla-
cental vessels ( table 4 ). Two studies reported on elective 
 Table 4. Reports on elective intrauterine interventions in monochorionic twin pregnancies presenting with sFGR-II with and without 
coexistent twin-to-twin transfusion syndrome at about 20 weeks’ gestation
 Management/first author n Survival Delivery, 
weekssmall twin large twin overall
24 0 21 (87.5%) 21 (43.8%) –
22 0 20 (90.9%) 20 (45.4%) 31.1
Cord occlusion
Bebbington, 2012 [11]
Chalouhi, 2013 [10]
Total 46 0 41 (89.1%) 41 (44.6%)
Endoscopic placental vessel laser
No twin-to-twin transfusion
8 3 (37.5%) 4 (50.0%) 7 (43.7%) 31.3
23 7 (30.4%) 17 (73.9%) 24 (52.2%) 32.5
142 55 (38.7%) 96 (67.6%) 151 (53.2%) 32.0
Quintero, 2001 [9]
Chalouhi, 2013 [10]
Peeva, 2015
Total 173 65 (37.8%) 117 (67.6%) 182 (52.6%) 32.0
Twin-to-twin transfusion
166 69 (41.6%) 92 (55.4%) 161 (48.5%) 32.5
405 161 (39.7%) 283 (69.8%) 444 (54.8%) 32.3
Chalouhi, 2013 [10]
Peeva, 2015
Total 571 230 (40.3%) 375 (65.7%) 605 (53.0%) 32.4
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occlusion of the umbilical cord of the FGR-II twin at 
about 20 weeks’ gestation; in the combined data on a total 
of 46 pregnancies, there was survival of the larger twin in 
89% of cases, and therefore the overall survival was 45% 
with delivery at a median gestational age of 31 weeks  [10, 
11] . Data on elective endoscopic laser coagulation of pla-
cental vessels in FGR-II without coexisting TTTS were
provided by 2 previous studies, and the results are similar 
to those in our study. In the combined data on a total of
173 pregnancies, there was survival of the smaller twin in 
38% of cases, of the larger twin in 68%, and the overall
survival was 52% with delivery at a median gestational age 
of 32 weeks  [9, 10] . Similar results were obtained in the
combined data from a previous study  [10] and our data
on a total of 571 pregnancies with FGR-II and coexisting
TTTS treated by elective endoscopic laser surgery.
 Implications for Clinical Practice 
 In sFGR-II presenting at 28 weeks’ gestation with ab-
normal Doppler findings in the ductus venosus, it would 
be reasonable to undertake early delivery if there is a good 
standard of neonatal care. If in such pregnancy the birth 
weight of the larger twin is on the 50th percentile, the 
weight of the smaller twin would be at least 25% less, 
which is equivalent to an average weight at 26 weeks  [15] .
 In the last 20 years, sFGR-II has been identified at the 
ultrasound examination that is routinely performed at 20 
weeks’ gestation. Indeed, many cases are now detected 
earlier because of the widespread uptake of the 11–13 
weeks’ scan and the policy of following up MCDA twins 
at 1–2 weekly intervals thereafter  [1, 21] .
 In sFGR-II presenting with abnormal Doppler find-
ings in the ductus venosus at about 20 weeks’ gestation, 
the likely outcome is fetal death of the smaller twin with 
consequent high risk of death or brain damage in the larg-
er twin. In such cases, the management of choice would 
be endoscopic laser coagulation of the inter-twin com-
municating placental vessels or cord occlusion of the FGR 
twin. The best option would be determined by the wishes 
of the parents, technical issues in carrying out the proce-
dure and local expertise. In terms of outcome, the two 
methods are associated with a similar gestational age at 
delivery and therefore likely risk of handicap. With cord 
occlusion, compared to laser surgery, it appears that the 
rate of survival of the larger twin may be higher but the 
overall survival is lower. However, these conclusions are 
drawn from the published data on all cases of FGR-II, 
rather than those with abnormal Doppler findings in the 
ductus venosus alone  [9–11] . In our series of such cases, 
only 12% of the small twins and 60% of the larger ones 
survived. On the assumption that with cord occlusion the 
survival of the larger twin is not related to the severity of 
the disease, reflected in the abnormal ductus venosus flow 
in the small twin, such intervention that sacrifices the 
small twin could improve the survival of the larger twin 
to about 90%  [10, 11] . If the rationale of this argument is 
accepted in cases of sFGR-II without TTTS, the same 
could be applied for cases with coexistent TTTS, and yet 
there is general agreement that the best option in the 
management of such cases is endoscopic laser surgery.
 In sFGR-II and normal Doppler findings in the ductus 
venosus at the time of diagnosis at about 20 weeks, the 
best choice between elective laser surgery, elective cord 
occlusion or expectant management with subsequent op-
tions of early delivery or emergency intrauterine inter-
vention remains uncertain. With expectant management, 
it is anticipated that in most cases there will be deteriora-
tion in the fetal condition leading to fetal death, extreme 
preterm delivery or the need for emergency intrauterine 
intervention  [2, 7] . It could therefore be argued that elec-
tive cord occlusion or laser surgery at about 20 weeks 
would be preferable. However, in some cases such inter-
ventions may be unnecessary because the fetuses could 
survive to a gestational age at which early delivery can 
safely be undertaken. The exact proportion that will fall 
into the groups of early and late deterioration and the 
method of predicting the speed of such deterioration re-
quire further investigation.
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 Introduction 
 Monochorionic (MC) pregnancies are often compli-
cated by severe feto-fetal transfusion syndrome (FFTS) 
and/or selective fetal growth restriction (sFGR). The es-
tablished treatment of choice in the management of se-
vere FFTS in MC twin pregnancies is endoscopic laser 
coagulation of the inter-twin communicating placental 
vessels  [1–3] . In sFGR with abnormal Doppler findings 
in the umbilical artery of the affected fetus, there is a high 
risk of perinatal death and handicap for both twins; the 
management for affected pregnancies presenting at mid-
gestation includes endoscopic laser coagulation of the 
inter-twin communicating placental vessels or cord oc-
clusion of the FGR twin  [4–8] . Few studies in a small 
number of patients have reported on endoscopic laser 
coagulation of communicating placental vessels for the 
management of FFTS in MC or dichorionic (DC) triam-
niotic (TA) triplet pregnancies complicated by FFTS  [9–
16] .
 The objectives of this study are to report our experi-
ence with endoscopic laser surgery in the management 
of severe FFTS or sFGR in MC and DC triplet pregnan-
cies and to compare the results with those of previous 
studies.
 Key Words 
 Monochorionic triplets · Dichorionic triplets · Feto-fetal 
transfusion syndrome · Selective fetal growth restriction · 
Endoscopic laser coagulation 
 Abstract 
 Objective: To report the outcome of monochorionic (MC) 
and dichorionic (DC) triamniotic (TA) triplet pregnancies 
treated with endoscopic laser coagulation of the communi-
cating placental vessels for severe feto-fetal transfusion syn-
drome (FFTS) and selective fetal growth restriction (sFGR). 
 Methods: Laser surgery was performed at 18 (15–24) weeks’ 
gestation in 11 MCTA and 33 DCTA pregnancies complicated 
by FFTS and 14 DCTA pregnancies complicated by sFGR. 
Data from our study and previous reports were pooled using 
meta-analytic techniques.  Results: Survival of at least one 
baby and survival among all fetuses was 97.0 and 72.7% in 
DCTA pregnancies with FFTS, 78.6 and 52.4% in DCTA preg-
nancies with sFGR and 81.8 and 39.4% in MCTA pregnancies 
with FFTS. In the combined data from our study and previous 
reports, the pooled survival rates in 132 DCTA pregnancies 
with FFTS were 94.4 and 76.1%, and in 29 MCTA pregnancies 
with FFTS, they were 80.6 and 57.5%.  Conclusions: Survival 
after laser surgery is higher in DC triplets with FFTS than in 
those with sFGR and in DC than in MC triplets with FFTS. 
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 Methods  
 Study Design and Participants 
 This was a retrospective study of all cases of MCTA and DCTA 
triplet pregnancies treated by endoscopic laser coagulation of 
communicating placental vessels at 15–24 weeks’ gestation in our 
fetal medicine centre between 1996 (4 years after we first intro-
duced endoscopic laser surgery in twins  [1] ) and June 2015. Um-
bilical cord occlusion was not a treatment option for sFGR or FFTS 
in our centre. The cases included 11 MCTA and 33 DCTA preg-
nancies complicated by FFTS and 14 DCTA pregnancies compli-
cated by sFGR without coexisting FFTS. 
 Chorionicity and amnionicity were established in the first tri-
mester as previously reported  [17] . Gestational age was calculated 
from the crown-rump length of the biggest fetus  [18] . The diagno-
sis of FFTS was made if there was a marked discordance in amni-
otic fluid volume between the MC fetuses with a deepest vertical 
pool of  ≤ 2 cm in at least one sac and of  ≥ 8 cm in the other; the 
severity of the disease was classified as stage I if the Doppler find-
ings in the umbilical artery and ductus venosus of both fetuses 
were normal and the bladder of the donor was visible, stage II with 
normal Doppler findings but no visible bladder, stage III with ab-
normal Doppler findings in either of the MC fetuses and stage IV 
with presence of ascites or hydrops in either MC fetus  [19] . 
 In the DCTA pregnancies, diagnosis of sFGR was based on the 
demonstration that, firstly, the abdominal circumference at <22 
weeks or estimated fetal weight at  ≥ 22 weeks was below the 5th 
percentile of the appropriate reference range  [20–22] and, second-
ly, the inter-twin discordance in estimated fetal weight (weight dif-
ference divided by the weight of the larger twin) was  ≥ 25%; the 
estimated fetal weight at <20 weeks was derived by the formula by 
Warsof et al.  [23] , and at  ≥ 20 weeks it was derived by the formula 
of Hadlock et al.  [21] . In all of our cases of sFGR, there was Dopp-
ler evidence of absent or reversed end-diastolic flow in the um-
bilical artery of the smaller fetus, and they were therefore classified 
as type II  [24] . 
 Endoscopic laser surgery was carried out transabdominally us-
ing a semi-rigid 2.0-mm diameter fetoscope (Karl Storz GmbH, 
Tuttlingen, Germany), through a 3.3-mm diameter cannula 
(Cook Medical, Bloomington, Ind., USA), after the administra-
tion of prophylactic antibiotics and local anaesthesia. In DC trip-
let pregnancies with FFTS or sFGR, the fetoscope was introduced 
into the sac of the larger fetus of the MC pair; a 400-μm diameter 
Nd:YAG laser fibre (Dornier MedTech, Wessling, Germany) and 
power output of 40 W was used to coagulate the inter-twin com-
municating placental vessels as previously described for MC twin 
pregnancies  [7] . In MC triplet pregnancies with FFTS, the feto-
scope was introduced into the sac of the recipient fetus, and laser 
was used to coagulate the vessels between this fetus and each of 
the other two fetuses; subsequently, the fetoscope was advanced 
through the inter-twin membrane into the sac of one of the oth-
er fetuses to coagulate the vascular connections between them. 
In cases of polyhydramnios, amnioreduction was undertaken 
through the cannula over a period of 10–15 min to obtain subjec-
tive normalization of the amniotic fluid volume. After a period of 
rest for 1–3 h, the patients were discharged home. Follow-up and 
management of the pregnancies was usually undertaken in the 
referral hospitals.
 Maternal demographic characteristics, ultrasound findings 
and details of intrauterine intervention were recorded in a data-
base. Pregnancy outcomes were collected into the same database 
when they became available from the referring hospitals, general 
practitioners or from the patients themselves.
 Comparison and Synthesis with Results from Previous Studies 
 Searches of Medline and Embase (August 2015) were per-
formed to identify all studies in the English language that reported 
on the use of endoscopic laser surgery for at least two triplet preg-
nancies. The inclusion criteria were DCTA or MCTA pregnancies 
complicated by FFTS and/or sFGR, treated by endoscopic laser 
and providing outcome data. In case of data duplication or overlap, 
only the largest or most recent study with available data was in-
cluded. 
 Statistical Analysis 
 Data from our study and previous reports were pooled using 
meta-analytic techniques. Random effects models were used to es-
timate weighted neonatal survival rates, with 95% confidence in-
terval (CI). Heterogeneity between studies was analysed using both 
Higgins’ I 2 and Cochran’s Q test  [25, 26] . 
 The statistical software package SPSS 20.0 (IBM SPSS Statistics 
for Windows, version 20.0, IBM Corp., Armonk, N.Y., USA) and 
StatsDirect version 2.0 (StatsDirect Statistical Software, UK, 2013) 
were used for data analysis. 
 Results 
 Study Population 
 During the study period of 1996–2015, we performed 
endoscopic laser coagulation of communicating placental 
vessels in 47 DCTA and 11 MCTA triplet pregnancies. 
The DCTA pregnancies included 14 with sFGR type II 
and 33 with FFTS; in the latter group, the Quintero stage 
was I in one, II in two, III in 29 and IV in one. In all MCTA 
pregnancies, the FFTS was stage III or IV; in 6 cases, there 
was one donor and one recipient, in 4 cases, there were 
two donors and one recipient, and in 1 case, there was one 
donor and two recipients.
 DCTA Triplet Pregnancies with FFTS 
 In the group of 33 DCTA triplet pregnancies with 
FFTS, endoscopic laser surgery was performed success-
fully in all cases at a median gestational age of 18 (range 
15–23) weeks ( table 1 ). There was survival to discharge 
from hospital in 72.7% babies, and there was at least one 
survivor in 97.0% of the pregnancies. The median gesta-
tional age at delivery of live births was 29 weeks, and 
68.8% were born at <32 weeks.
 In 15 pregnancies, all three babies survived after deliv-
ery at 8–16 weeks following laser surgery. In 10 pregnan-
cies, two babies survived. In 8 cases, the donor triplet died 
either in utero or in the neonatal period at 1–14 weeks 
after laser surgery; the recipient triplet and the separate 
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one were live born and survived. In 1 case, selective feto-
cide of the donor twin was carried out by intracardiac 
injection of potassium chloride immediately after the la-
ser ablation at 17 weeks’ gestation because, at presenta-
tion, this fetus was found to have ventriculomegaly and 
hyperechogenicity of the cerebral cortex; the other two 
babies were born 13 weeks later and survived. In another 
case, treated at 20 weeks’ gestation, selective fetocide of 
the separate fetus was carried out because of the diagnosis 
of cerebellar atrophy after presentation with ruptured 
membranes at 29 weeks’ gestation; the other two babies 
were live born and survived. In 7 pregnancies, both MC 
twins died, 6 twins within 2 weeks and one set of twins 4 
weeks after laser surgery; in these cases, the separate trip-
let was live born and survived. In 1 pregnancy, all three 
babies died; the MC pair died 2 weeks after laser, and this 
was followed by spontaneous birth at 25 weeks’ gestation 
of the separate triplet that died in the neonatal period. 
 DCTA Triplet Pregnancies with sFGR 
 In the group of 14 DCTA triplet pregnancies with 
sFGR, endoscopic laser surgery was performed success-
fully in all cases at a median gestational age of 18 (range 
16–24) weeks ( table 1 ). There was survival to discharge 
from hospital in 52.4% babies, and there was at least one 
survivor in 78.6% of the pregnancies. The median gesta-
tional age at delivery of live births was 32 weeks, and 
45.5% were born at <32 weeks.
 In 1 pregnancy, all three babies survived after delivery 
at 32 weeks’ gestation following laser surgery at 18 weeks. 
In 9 pregnancies, the FGR triplet died within 2 weeks of 
laser surgery, but the other two babies were live born 6–20 
weeks later and survived. In 1 pregnancy, the MC twins 
died 1 week after laser surgery at 17 weeks; the separate 
triplet was live born at 37 weeks and survived. In 3 preg-
nancies, all three babies died; in the first case, there was 
miscarriage within 1 week of laser surgery, in the second 
case, the MC pair died within 2 weeks after laser and this 
was followed by miscarriage of the separate triplet 3 weeks 
later, and in the third case, the pregnancy progressed un-
eventfully after laser surgery at 17 weeks’ gestation, but all 
three fetuses died after prelabor amniorrhexis and cho-
rioamnionitis at 28 weeks.
 MCTA Triplet Pregnancies 
 In the first 4 cases of the series, there was laser coagu-
lation of the communicating vessels between the recipi-
ent triplet and the other two fetuses. In the subsequent 7 
cases, after completion of the first step as above, the feto-
scope was advanced through the inter-twin membrane 
into the sac of one of the other fetuses to coagulate the 
vascular connections between them.
 Endoscopic laser surgery was performed at a median 
gestational age of 18 (range 16–23) weeks ( table 1 ). There 
was survival to discharge from hospital in 39.4% babies, 
and there was at least one survivor in 81.8% of the preg-
nancies. The median gestational age at delivery of live 
births was 32 weeks, and 66.7% were born at <32 weeks.
 In 1 pregnancy, all three babies survived after delivery 
at 30 weeks’ gestation following laser surgery at 19 weeks. 
In 2 pregnancies, the donor triplet died within 2 weeks of 
laser surgery at 16 and 20 weeks’ gestation, respectively, 
but the other two babies were live born 14 and 8 weeks 
later and survived. In 6 pregnancies, there was only one 
survivor; donor and recipient triplets died within 4 weeks 
after laser surgery. In 2 pregnancies, all three babies died; 
there was miscarriage within 1 week of laser surgery.
 Comparison of Survival between the Triplet 
Pregnancies 
 Survival of at least one baby in the DCTA pregnancies 
with FFTS (97.0%) was not significantly different from 
that in DCTA pregnancies with sFGR (78.6%; p = 0.790) 
or MCTA pregnancies with FFTS (81.8%; p = 0.276). 
Overall survival for all fetuses in the DCTA pregnancies 
with FFTS (72.7%) was significantly higher than in DCTA 
pregnancies with sFGR (52.4%; p = 0.003) or MCTA 
pregnancies with FFTS (33.3%; p < 0.0001). 
 Table 1. Outcome of our triplet pregnancies treated by endoscopic 
laser surgery
Outcome measure DCTA, 
FFTS
(n = 33)
DCTA, 
sFGR
(n = 14)
MCTA, 
FFTS
(n = 11)
GA at laser surgery, 
18 (15 – 23) 18 (16 – 24) 18 (16 – 23)weeks
Survival
15 (45.5) 1 (7.1) 1 (9.1)
10 (30.3) 9 (64.3) 2 (18.2)
Three
Two
One 7 (21.2) 1 (7.1) 6 (54.5)
32 (97.0) 11 (78.6) 9 (81.8)> one
Overall 72 (72.7) 22 (52. 13 (39.
GA at delivery of 
live births, weeks 29 (24 – 36) 32 (28 – 36) 32 (28 – 42)
<32 weeks, 
n/total n (%)
22/32 
(68.8)
5/11 (45.5) 6/9 
(66.7)
 Values are medians (ranges) or n (%), unless otherwise 
specified. GA = Gestational age.
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 Synthesis with Results from Previous Studies  
 The literature search identified 8 previous studies re-
porting data on DCTA pregnancies with FFTS treated by 
endoscopic laser surgery, and the combined data from 
these studies with ours are shown in  table 2 and  figure 1 
 [9–16] . In a total of 132 such pregnancies, the pooled sur-
vival rate of at least one baby was 94.4% (95% CI 90.1–
97.6), and the overall survival for all babies was 76.1% 
(95% CI 71.9–80.2); there was no significant heterogene-
ity between the studies. Delivery in live births at <32 
weeks’ gestation occurred in 56.7% (95% CI 43.1–69.8) of 
cases.
 The literature search identified 5 previous studies re-
porting data on MCTA pregnancies with FFTS treated 
by endoscopic laser surgery, and the combined data 
from these studies with ours are shown in  table 3 and 
 Table 2. Studies reporting on endoscopic laser surgery for FFTS in DCTA triplet pregnancies
Study Period Median GA at 
laser surgery 
(range), weeks
Total,
n
Stage 3/4,
n (%)
Survival of >1 baby,
n/total n (%, 95% CI)
Overall survival,
n/total n (%, 95% CI)
Live birth at <32 weeks, 
n/total n (%, 95% CI)
Van Schoubroeck et al.
[9], 2004 
1996 – 
2002
20 (18 – 23) 5 5 (100) 5/5 (100, 47.8 – 100) 12/15 (80.0, 51.9 – 95.7) 4/5 (80.0, 28.4 – 99.5)
De Lia et al. [11], 2009 1992 – 
2008
21 (18 – 25) 8 7 (87.5) 8/8 (100, 63.1 – 100) 20/24 (83.3, 62.6 – 95.3) 2/8 (25.0, 3.2 – 65.1)
Chmait et al. [12], 2010 1998 – 
2008
20 (16 – 24) 40 26 (65. 37/40 (92. – 98.4) 92/120 (76  – 83.9) not known
Diemert et al. [13], 2010 2004 – 
2008
20 (17 – 23) 13 9 (69.2 11/13 (84. – 98.1) 27/36 (75.0, 57.8 – 87.9) 7/11 (63.6, 30.8 – 89.1)
Peeters et al. [14], 2012 2000 – 
2012
18 (15 – 25) 8 4 (50.0) 8/8 (100, 63.1 – 100) 19/24 (79.2, 57.8 – 92.9) 4/8 (50.0, 15.7 – 84.3)
Argoti et al. [15], 2014 2005 – 
2011
20 (15 – 25) 16 13 (81. 16/16 (100, 79.4 – 100) 39/48 (81.  –91.1) not known
Ishii et al. [16], 2014 2007 – 
2013
21 (16 – 25) 9 6 (66.7) 9/9 (100, 66.4 – 100) 20/27 (74.1, 53.7 – 88.9) 4/9 (44.4, 13.7 – 78.8)
Our studya 1996 – 
2015
18 (15 – 23) 33 30 (90. 32/33 (97.0, 84.2 – 100) 72/99 (72.  –81.2) 22/32 (68.  –83.9)
Pooled analysis 132 126/132 (9  – 97.6) 301/393 (7 –80.2) 43/73 (56.  –69.8)
Cochran’s Q (p value) 4.3230 (0.7419) 2.0919 (0.9546) 6.8491 (0.2321)
I2 statistic, % (95% CI) 0 (0 – 56.3) 0 (0 – 56.3) 27 (0 – 70.7)
GA = Gestational age. a Including data from Sepulveda et al. [10]. 
 Table 3. Studies reporting on endoscopic laser surgery for FFTS in MCTA triplet pregnancies
Study Period Median GA at 
laser surgery 
(range), weeks
Total,
n
Stage 3/4,
n (%)
Survival of >1 baby,
n/total n (%, 95% CI)
Overall survival
n/total n (%, 95% CI)
Live birth at <32 weeks,
n/total n (%, 95% CI)
De Lia et al. [11], 2009 1992 – 
2008
21 (18 – 25) 2 1 (50.0 1/2 (50.0  – 98.7) 3/6 (50.0, 11.8 – 88.2) 1/2 (50.0, 1.3 – 98.7)
Chmait et al. [12], 2010 1998 – 
2008
19 (17 – 22) 6 2 (33.3 5/6 (83.3, – 99.6) 11/18 (61.1, 35.7 – 82.7) 4/5 (80.0, 28.4 – 99.5)
Diemert et al. [13], 2010 2004 – 
2008
19 (18 – 20) 3 1 (33.3 2/3 (66.7  – 99.2) 5/9 (55.6, 21.2 – 86.3) 1/2 (50.0, 1.3 – 98.7)
Ishii et al. [16], 2014 2007 – 
2013
20 (17 – 22) 7 4 (57.1 7/7 (100, 59.0 – 100) 18/21 (85.7, 63.7 – 97.0) 5/7 (71.4, 29.0 – 96.3)
Our studya 1996 – 
2015
18 (16 – 23) 11 11 (100.0) 9/9 (81.8, 48.2 – 97.7) 11/33 (33.3, 18.0 – 51.8) 6/9 (66.7, 29.9 – 92.5)
Pooled analysis 29 24/29 (80.6, 64.9 – 92.4) 48/87 (57.5, 36.2 – 77.4) 17/25 (65.4, 47.7 – 81.1)
Cochran’s Q (p value) 4.3804 (0.3570) 15.9245 (0.0031) 0.9285 (0.9204)
I2 statistic, % (95% CI) 8.7 (0 – 67.1) 74.9 (6.1 – 87.9) 0 (0 – 64.4)
GA = Gestational age. a Including data from Sepulveda et al. [10].
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 figure 2  [10–13, 15] . In a total of 29 such pregnancies, the 
pooled survival rate of at least one baby was 80.6% (95% 
CI 64.9–92.4), and the overall survival for all babies was 
57.5% (95% CI 36.2–77.4); there was significant hetero-
geneity between the studies. Delivery in live births at <32 
weeks’ gestation occurred in 65.4% (95% CI 47.7–81.1) 
of cases.
 Discussion 
 The ﬁndings of this study demonstrate the feasibility of 
endoscopic laser coagulation of communicating placental 
vessels in the treatment of MC and DC triplet pregnancies 
complicated by severe FFTS or sFGR. In DC triplets, the 
separate fetus can pose some technical problems in select-
ing the appropriate site of entry of the fetoscope, but in 
Study At least one survivor  Survival among all babies
% (95% CI) Weight,
%
% (95% CI) Weight,
%
100 (47.8 – 100) 4.3 80.0 (51.9 – 95.7) 4.0
100 (63.1 – 100) 6.4 83.3 (62.6 – 95.3) 6.2
92.5 – 98.4) 29.3 76.7 (68.1 – 83.9) 30.2
54.5 (84.6 – 98.1) 10.0 75.0 (57.8 – 87.9) 9.2
100 (63.1 – 100) 6.4 79.2 (57.8 – 92.9) 6.2
100 (79.4 – 100) 12.1 67.4 (81.3 – 91.1) 12.2
100 (66.4 – 100) 7.1 74.1 (53.7 – 88.9) 7.0
97.0 (84.2 – 100) 24.3 72.7 (62.9 – 25.0
Van Schoubroeck et al. [9], 2004 
De Lia et al. [11], 2009 
Chmait et al. [12], 2010 
Diemert et al. [13], 2010 
Peeters et al. [14], 2012 
Argoti et al. [15], 2014 
Ishii et al. [16], 2014 
Our study
Pooled analysis 94.4 (90.1 – 100.0 76.1 (71.9 – 80.2) 100.0
40 60 80
Survival (%) (95% CI)
100 50 70 90
Survival (%) (95% CI)
110
 Fig. 1. Pooled estimates of rates of at least one survivor and survival among all babies in DC triplet pregnancies 
treated with laser coagulation of placental vessels for FFTS. 
Study At least one survivor  Survival among all babies
% (95% CI) Weight,
%
% (95% CI) Weight,
%
50.0 (1.26 – 98.7) 9.5
83.3 (35 20.9
66.7 (9. 12.5
100 (59.0 – 100) 23.6
81.8 (48 33.6
De Lia et al. [11], 2009 
Chmait et al. [12], 2010 
Diemert et al. [13], 2010 
Ishii et al. [16], 2014 
Our study
Pooled analysis 80.6 (64.9 – 92.4) 100.0
50.0 (11.8 – 88.2) 15.3
61.1 (35.7 – 82.7) 21.3
55.6 (21.2 – 86.3) 17.6
85.7 (63.7 – 97.0) 22.0
33.3 (18.0 – 51.8) 23.8
57.5 (36.2 – 77.4) 100.0
0 20 40 60
Survival (%) (95% CI)
80 100 0 20 40 60
Survival (%) (95% CI)
80 100
 Fig. 2. Pooled estimates of rates of at least one survivor and survival among all babies in MC triplet pregnancies 
treated with laser coagulation of placental vessels for FFTS. 
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general, these problems can easily be overcome; conse-
quently, the outcome of affected pregnancies either by 
FFTS or sFGR is similar to that in MC twins but with an  inevitable higher incidence of early preterm birth. In con-
trast, in MC triplets, endoscopic laser surgery can be tech-
nically difficult because of the necessity to coagulate the 
communicating placental vessels between all three fetuses; 
as a result of such technical problems or the inability to 
achieve the objective of complete separation between all 
fetuses, the outcome is poorer than in DC triplets. 
 In the combined data from this and previous studies, 
in DC triplets with FFTS, there was survival of at least one 
baby in about 95% of pregnancies and survival of 75% of 
all babies. These results are compatible with those of en-
doscopic laser surgery in MC twins with severe FFTS. 
However, in the triplet pregnancies, a very high propor-
tion of survivors, about 60%, were born at <32 weeks’ ges-
tation. We have previously reported that in trichorionic 
triplet pregnancies with three live fetuses at 10–14 weeks’ 
gestation that were managed expectantly, 35% delivered 
at <33 weeks; the rate in DC triplet pregnancies managed 
expectantly was 46%  [27] . The higher rate of preterm 
birth in DC triplets complicated by severe FFTS and treat-
ed by endoscopic laser surgery is not surprising.
 In our DC triplets with sFGR type II, there was sur-
vival of at least one baby in 79% of pregnancies and sur-
vival of 52% of all babies. These results are compatible 
with findings in our series of 547 MC twin pregnancies 
with sFGR type II treated with endoscopic laser surgery; 
there was survival of at least one baby in 72% of pregnan-
cies, and 54% of all babies survived  [7] . However, surviv-
al of the growth-restricted fetus in our DC triplets (7%) 
was lower than in our MC twin pregnancies with sFGR 
(40%), possibly because the placental territory of the 
growth-restricted fetus in DC triplets may be smaller than 
in MC twins.
 In the DC triplets with sFGR type II, 46% of survivors 
were born at <32 weeks’ gestation. A likely explanation 
for this lower rate of early preterm birth than in our DC 
triplets with FFTS treated with endoscopic laser (46 vs. 
69%) is that following laser surgery, 93% of pregnancies 
with sFGR continued to delivery with only one or two live 
fetuses, whereas in those with FFTS, the equivalent rate 
was 54%; consequently, in relation to preterm birth, only 
7% in the sFGR group versus 46% in the FFTS group be-
haved as triplet pregnancies.
 In MC triplets with severe FFTS, in comparison to DC 
triplets with FFTS, survival was poorer. In our MC trip-
lets, at least one baby survived in 82 of the pregnancies, 
and 39% of all babies survived, compared to the respective 
rates of 97 and 73% in our series of DC triplets. The num-
ber of MC triplets is too small for definite conclusions to 
be drawn, but it is certain that endoscopic laser surgery in 
these pregnancies is considerably more difficult than in 
DC triplets.
 The results from endoscopic laser surgery in triplet 
pregnancies in our series and those from previous small-
er studies allow some general conclusions to be drawn on 
the effectiveness of such therapy and overall survival 
rates. However, the total number of cases is still too small 
to allow accurate assessment of outcome according to 
subgroups of triplets, including MC and DC complicated 
by FFTS and/or sFGR, different stages of FFTS, gestation-
al age at therapy or techniques of endoscopic laser sur-
gery. 
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ABSTRACT
Objective To report the outcome of dichorionic (DC)
triplet pregnancies reduced to DC twins by laser ablation
of the pelvic vessels of one of the monochorionic (MC)
twins.
Methods Intrafetal laser embryo reduction (ER) fromDC
triplets to DC twins was carried out in 61 pregnancies at
11 + 0 to 14 + 3 weeks’ gestation. Pregnancy outcome
was examined.
Results Intrafetal laser was successfully carried out in all
cases, but ultrasound examination within 2 weeks of the
procedure demonstrated that the MC cotwin had died in
28 (45.9%) cases andwas alive in the other 33 (54.1%). In
the DC group, there was one miscarriage at 23 weeks, one
neonatal death after delivery at 26 weeks and in the other
31 cases there were two live births at a median gestational
age of 35.3 (range, 30.4–38.4) weeks. In the 28 cases in
which both MC fetuses died, there was one miscarriage at
16 weeks and in the other 27 cases the separate triplet was
liveborn at a median gestation of 38.2 (range, 32.2–42.1)
weeks. The overall rate of miscarriage was 3.3% (2/61)
and that of preterm birth (PTB) at < 33 weeks was 6.8%
(4/59).
Conclusions In the management of DC triplet preg-
nancies, ER to DC twins by intrafetal laser ablation
is associated with lower rates of miscarriage or early
PTB, compared with expectant management or ER by
fetal intracardiac injection of potassium chloride. How-
ever, about half of the pregnancies result in the birth of
one rather than two babies. Copyright © 2017 ISUOG.
Published by John Wiley & Sons Ltd.
INTRODUCTION
In triplet pregnancies diagnosed during the first trimester,
management options include continuing with the whole
pregnancy or embryo reduction (ER) to twins or
Correspondence to: Prof. K. H. Nicolaides, Fetal Medicine Research Institute, King’s College Hospital, 16–20 Windsor Walk, Denmark Hill,
London SE5 8BB, UK (e-mail: kypros@fetalmedicine.com)
Accepted: 1 August 2017
singletons. In trichorionic (TC) triplets, ER is achieved by
fetal intracardiac injection of potassium chloride (KCl).
The beneficial consequence of ER is decrease in the rate
of early preterm birth (PTB) at < 33 weeks’ gestation;
a large study and review of the literature of TC triplets
diagnosed at 10–14 weeks reported that PTB at < 33
weeks occurred in 35% of those managed expectantly
and this was reduced to 13% after ER to twins and 9%
after ER to singletons1. However, such benefit was at the
expense of the rate of miscarriage at < 24 weeks, which
increased from 3% with expectant management to 7%
after ER to twins and 12% after ER to singletons.
In dichorionic (DC) triplet pregnancies, ER by KCl
involves either the DC fetus or both monochorionic
twins; the injected KCl to only one of the monochorionic
twins could be transferred to the cotwin through the
intertwin placental vascular anastomoses or death of
one fetus could lead to hemorrhage from the cotwin
into the dead fetoplacental unit with consequent death
or neurodevelopmental impairment in the survivor. In
DC triplet pregnancies, compared with TC triplets, there
is a higher rate of miscarriage both with expectant
management (9% vs 3%)1–5 and after ER to twins (13%
vs 7%)1, which could, at least in part, be attributed to
complications arising from intertwin placental vascular
communications and/or unequal sharing of the placenta
in the monochorionic pair.
We have proposed a new approach for ER of DC
triplet pregnancies to DC twins by ultrasound-guided laser
ablation of the pelvic vessels of one of the monochorionic
twins6. In a series of 22 DC triplet pregnancies undergoing
intrafetal laser, ultrasound examination within 2 weeks
of the procedure demonstrated that the cotwin had died
in 11 cases and was alive in the other 11; in the DC
group there was one miscarriage at 23 weeks and in the
other 10 cases there were two live births at a median
gestational age of 35 weeks, whereas in the 11 cases
in which both monochorionic fetuses died, the separate
triplet was liveborn at a median gestation of 38 weeks.
Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd. ORIGINAL PAPER
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Both fetuses alive (n = 33) One fetus alive (n = 28)
Dichorionic triplets with laser reduction
to dichorionic twins at 11–14 weeks
(n = 61)
Ultrasound examination within 2 weeks
One survivor (n = 27)
Miscarriage
(n = 1), 16 weeks 
Birth < 32 weeks
Birth < 33 weeks
Birth < 34 weeks
Birth ≥ 34 weeks
n = 0
n = 1 (3.7%)
n = 1 (3.7%)
n = 26 (96.3%)
n = 2 (6.5%)
n = 3 (9.7%)
n = 8 (25.8%)
n = 23 (74.2%)
Two survivors (n = 31)
Miscarriage
(n = 1), 23 weeks
NND + LB at
26 weeks
(n = 1)
Median GA
at birth
38.2 weeks35.3 weeks
Figure 1 Flowchart summarizing pregnancy outcome of
dichorionic triplet pregnancies reduced to dichorionic twins with
ultrasound-guided intrafetal laser ablation. GA, gestational age;
LB, livebirth; NND, neonatal death.
At the end of the ER procedure and 1 h later both
remaining DC twins were alive and there was no blood
flow within the dead fetus. Ultrasound examination
within 2 weeks of the procedure demonstrated that both
fetuses were alive in 33 (54.1%) cases and that the
monochorionic cotwin had died in 28 (45.9%) (Figure 1).
In the DC group, there was one miscarriage at 23 weeks
due to cervical incompetence, one neonatal death after
spontaneous delivery at 26 weeks and in the other 31
cases there were two live births at a median gestational
age of 35.3 (range, 30.4–38.4) weeks. In the 28 cases in
which both monochorionic fetuses died, there was one
miscarriage at 16 weeks and in the other 27 cases the
separate triplet was liveborn at a median gestation of
38.2 (range, 32.2–42.1) weeks. None of the neonates had
any obvious defect or neurological deficit. In the total
group, the rates of miscarriage and PTB at < 33 weeks
were 3.3% (2/61) and 6.8% (4/59), respectively.
DISCUSSION
Principal findings of this study
The findings of this study demonstrate that, in the
management of DC triplet pregnancies, ER to DC twins
2
The objective of this study of 61 DC triplet pregnancies
undergoing intrafetal laser ablation was to provide an
update on the outcome of such pregnancies.
METHODS
Intrafetal laser ablation for ER from DC triplets to
DC twins was carried out in 61 pregnancies referred
to one of two fetal medicine units between 2004 and
2016. In all cases, ultrasound examination was carried
out at 10–14 weeks’ gestation to demonstrate three
live fetuses, determine chorionicity from examination of
the inter-triplet membranes7 and calculate gestational
age from the crown–rump length (CRL) of the largest
fetus8. Parents were counseled regarding the options of
expectant management or ER. Maternal demographic
characteristics, ultrasound findings and, in those under-
going ER, details of the procedure were recorded in a
database. Pregnancy outcomes were collected in the same
database when they became available from the referring
hospitals, general practitioners or the patients themselves.
Intrafetal laser ER was carried out as previously
described6. Color flow Doppler was used to visualize the
internal iliac arteries and intra-abdominal umbilical vein
of one of the monochorionic twins. Local anesthesia was
administered to the maternal abdomen. Under continuous
ultrasound visualization, an 18-G needle was inserted
into the fetal abdomen adjacent to the pelvic vessels, a
400-μm laser fiber was then inserted into the needle and
advanced to a couple of millimeters beyond the tip of
the needle and laser coagulation was performed using an
Nd:YAG laser (Dornier Med Tech, Wessling, Germany)
with 40 W. This resulted in hyperechogenicity of tissues
in the lower abdomen and cessation of blood flow in
the iliac arteries and umbilical vein. Fetal heart activity
continued for several minutes. After a period of rest
for about 60min, another ultrasound examination was
carried out to confirm death of one monochorionic twin
and survival of a DC pair. The patient was discharged
and a further appointment was made for an ultrasound
examination within 2 weeks of the procedure.
RESULTS
In the study population of 61 DC triplet pregnancies
undergoing ER to twins by intrafetal laser ablation,
conception was spontaneous in eight (13.1%) and by
in-vitro fertilization in 53 (86.9%). The median maternal
age was 34 (range, 19–46) years and the median
gestational age at ER was 12.3 (range, 11.0–14.3) weeks.
Ultrasound examination had demonstrated that all
three fetuses in each pregnancy were alive. There were
no obvious defects in any of the separate fetuses. In the
monochorionic twins, one fetus had diaphragmatic her-
nia, one had a major cardiac defect and one had acrania;
in 18 (29.5%) cases there were early signs of twin-to-twin
transfusion syndrome or selective fetal growth restriction
with large discordance in CRL (>10%) and/or reversed
a-wave in the ductus venosus in one of the fetuses.
Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2017.
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two survivors in seven and one survivor in three; PTB at
< 33 weeks occurred in 40% (4 of 10) of cases.
Implications for practice
In DC triplet pregnancies, counseling of the parents
concerning management options should include intrafetal
laser reduction to DC twins. Intrafetal laser is associated
with a substantially lower rate of miscarriage, compared
with that with expectant management or ER to twins
or singleton by fetal intracardiac injection of KCl. The
rate of PTB at <33 weeks’ gestation is also considerably
lower than with expectant management or ER by KCl
to monochorionic twins, but is similar to that of ER to
singleton. However, with intrafetal laser ablation, about
half of the pregnancies will result in the birth of one
rather than two babies.
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Embryo reduction by laser in dichorionic triplets
by intrafetal laser ablation is an additional option to
the traditional ones of expectant management, ER by
intrafetal injection of KCl to monochorionic twins or
ER by KCl to singleton. In 87% of our DC triplet
pregnancies, conception was by in-vitro fertilization. The
risk of monozygotic twinning in assisted conception is
more than five times as high as the 0.4% rate in natural
conceptions9–12. The increased rate of embryo splitting
has been attributed to prolonged embryo culture and
delayed transfer at the blastocyst rather than cleavage
stage and, possibly, zona pellucida manipulation, oocyte
age and type of culture medium11,12.
The technique of ER utilizing interstitial laser is
similar to that used in interrupting the blood supply
of the acardiac twin in twin reversed arterial perfusion
sequence13. In our cases of DC triplet pregnancy treated
by intrafetal laser, although all monochorionic cotwins
were alive 1 h after the procedure, 46% of these twins
died within the subsequent 2 weeks. The most likely
explanation for the deaths was retrograde hemorrhage
into the placenta of the dead fetus or the fetus itself if the
occlusion of the fetal pelvic vessels was incomplete.
In the DC triplet pregnancies undergoing intrafetal
laser, the rate of miscarriage (3%) was considerably lower
than the reported rate in DC triplets managed expectantly
(9%)1–5, and those having ER by KCl to monochorionic
twins (13%)1 or singleton (18%)1–3,5. The rate of PTB
at < 33 weeks’ gestation was considerably lower with
intrafetal laser (7%) than with expectant management
(35%)1,3 or ER by KCl to monochorionic twins (13%)1,
and it was similar to that of ER to singleton (9%)1,3.
Strengths and limitations
The strengths of this study relate to the large number
of pregnancies treated by intrafetal laser, the narrow
gestational range at which treatment was undertaken and
the complete follow-up of cases.
A limitation of any study of this nature is the positive
bias in terms of favorable outcome in comparison with
historical controls managed expectantly or by intracardiac
injection of KCl. Ultimately, accurate comparisons can
be provided from randomized trials comparing different
management options, but it is very unlikely that such
studies will ever be undertaken.
Comparison with previous studies
One other study has reported on the outcome of a series of
DC triplet pregnancies managed by occlusion of the blood
supply to one of the monochorionic pair3. In this mul-
ticenter study, ultrasound-guided laser or radiofrequency
ablation of pelvic vessels was carried out in 12 DC triplet
pregnancies at 10–14 weeks’ gestation. Two (17%) preg-
nancies miscarried and in the remaining 10 there were
Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2017.
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STUDY 1  
Peeva G, Bower S, Orosz L, Chaveeva P, Akolekar R, Nicolaides KH: Endoscopic placental 
laser coagulation in monochorionic diamniotic twins with type II selective fetal growth 
restriction. Fetal Diagn Ther 2015; 38: 86-93.  
The objective of this study was to determine predictors of survival in monochorionic 
diamniotic twins with selective fetal growth restriction type II (sFGR-II), with or without twin-to-
twin transfusion syndrome, treated by endoscopic placental laser coagulation.   
Laser surgery was performed at 20 (15-27) weeks’ gestation in 405 cases of sFGR-II with 
and in 142 without coexisting TTTS. Multivariable logistic regression analysis was performed 
to determine significant predictors of survival to discharge from hospital from the following 
variables: degree of discordance in estimated fetal weight, coexisting TTTS, abnormal 
Doppler findings in the umbilical artery and ductus venosus of the smaller and larger twins, 
placental location, gestational age and cervical length at laser. 
There was survival of the small twin in 216 (39.5%) and of the large twin in 379 (69.3%) 
cases. Significant predictors of survival of both the small and larger twin were ductus 
venosus Doppler findings in the small twin, gestational age at laser and cervical length, but 
not the presence of TTTS or Doppler findings in the large twin. 
It was concluded that in sFGR-II survival after laser surgery is primarily dependent on the 
condition of the small twin. 
!91
SUMMARY 
!  
STUDY 2 
Peeva G, Chaveeva P, Gil Guevara E, Akolekar R, Nicolaides KH: Endoscopic placental 
laser coagulation in dichorionic and monochorionic triplet pregnancies. Fetal Diagn Ther 
2016; 40: 174-180. 
The objective of this study was to determine the outcome of monochorionic and dichorionic 
triamniotic triplet pregnancies treated with endoscopic laser coagulation of communicating 
placental vessels for severe feto-fetal transfusion syndrome and selective fetal growth 
restriction.  
Laser surgery was performed at 18 (15-24) weeks´ gestation in 11 MCTA and 33 DCTA 
pregnancies complicated by FFTS and 14 DCTA pregnancies complicated by sFGR. Data 
from our study and previous reports were pooled using meta-analytic techniques. 
Survival of at least one baby and survival among all fetuses was 97.0% and 72.7% in 
DCTA pregnancies with FFTS, 78.6% and 52.4% in DCTA pregnancies with sFGR and 
81.8% and 39.4% in MCTA pregnancies with FFTS. The literature search identified eight 
previous studies reporting data on DCTA pregnancies with FFTS treated by endoscopic 
laser surgery and five previous studies reporting data on MCTA pregnancies with FFTS 
treated by endoscopic laser surgery. In the combined data from our study and previous 
reports, the pooled survival rates in 132 DCTA pregnancies with FFTS were 94.4% and 
76.1% and in 29 MCTA pregnancies with FFTS were 80.6% and 57.5%. 
It was concluded that survival after laser surgery is higher in DC triplets with FFTS than 
those with sFGR and in DC than MC triplets with FFTS.  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STUDY 3  
Chaveeva P, Peeva G, Gil Pugliese S, Shterev A, Nicolaides KH: Intrafetal laser for embryo 
reduction from dichorionic triplets to dichorionic twins. Ultrasound Obstet Gynecol 2017; Aug 
9. doi: 10.1002/uog.18834 
The objective of this study was to determine the outcome of dichorionic triplet pregnancies 
reduced to dichorionic twins by laser ablation of the pelvic vessels of one of the 
monochorionic twins.  
Intrafetal laser embryo reduction from dichorionic triplet to dichorionic twins was carried out 
in 60 pregnancies at 11+0 - 14+3 weeks’ gestation. Pregnancy outcome was examined and 
compared to previous studies in DCTs managed expectantly or by ER to twins or singleton 
with fetal intracardiac injection of potassium chloride. 
Intrafetal laser was successfully carried out in all cases, but ultrasound examination within 
two weeks of the procedure demonstrated that the co-twin had died in 28 (46.7%) cases 
and was alive in the other 32 (53.3%). In the dichorionic group there was one miscarriage 
at 23 weeks due to cervical incompetence, one neonatal death after spontaneous delivery 
at 26 weeks and in the other 30 cases there were two live births at a median gestational 
age of 35.8 (range 30.4-38.4) weeks. In the 28 cases where both monochorionic fetuses 
died there was one miscarriage at 16 weeks and in the other 27 cases the separate triplet 
was live born at a median gestation of 38.3 (range 32.2-42.1) weeks. In DCTs intrafetal 
laser was associated with lower rate of miscarriage (3%), compared to that with expectant 
management (9%) or ER by intracardiac injection of KCl to monochorionic twins (13%) or 
singleton (18%). The rate of PTB at <33 weeks’ gestation (9%) was also lower than with 
expectant management (38%) or ER by intracardiac KCl to monochorionic twins (23%), 
but the same as with ER to singleton (9%).  
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It was concluded that in the management of DCT pregnancies, ER to dichorionic twins by 
intrafetal laser is associated with lower rates of miscarriage or early PTB, compared to 
expectant management or ER by intrafetal injection of KCl. However, about half of the 
pregnancies result in the birth of one rather than two babies. 
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The studies in this thesis have to a large extent fulfilled the 
objectives as outlined in chapter 1.6.
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Study 1 of a large series of 547 MC diamniotic twin pregnancies with sFGR type II, with or 
without TTTS, treated by endoscopic placental laser coagulation has shown that survival of 
the small twin was about 40% and of the large twin was 70%. Significant predictors of 
survival of both the small and larger twin were ductus venosus Doppler findings in the 
small twin, gestational age at laser and cervical length, but not the presence of TTTS or 
Doppler findings in the large twin. Consequently, in sFGR type II survival after laser surgery 
is primarily dependent on the condition of the small twin. 
Study 2 of 11 MC and 47 DC triplet pregnancies complicated by severe feto-fetal 
transfusion syndrome and / or sFGR treated by endoscopic placental laser coagulation has 
shown that survival was higher in DC triplets with FFTS than those with sFGR and in DC 
than MC triplets with FFTS. There was survival of at least one baby in 97% of DC triplets 
with FFTS, 79% of DC triplets with sFGR and 82% of MC triplets with FFTS. 
Study 3 of 60 DC triplet pregnancies undergoing ER to DC twins by intrafetal laser has 
demonstrated the feasibility of this technique. Such intervention is associated with 
substantially lower rates of miscarriage and early preterm birth, compared to expectant 
management or ER by intrafetal injection of KCl. However, about half of the pregnancies 
result in the birth of one rather than two babies. 
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ENGLISH 
Conclusions of the first study 
Endoscopic placental laser coagulation was carried in 547 monochorionic diamniotic twins 
with sFGR-II, including 405 with coexisting TTTS.  There was survival of the small twin in 
40% and of the large twin in 69% of cases. Significant predictors of survival of both the 
small and larger twin were ductus venosus Doppler findings in the small twin, gestational 
age at laser and cervical length, but not the presence of TTTS or Doppler findings in the 
large twin. Consequently, in sFGR-II survival after laser surgery is primarily dependent on 
the condition of the small twin. 
Conclusions of the second study 
Endoscopic placental laser coagulation was carried in 11 MCTA and 33 DCTA 
pregnancies complicated by FFTS and 14 DCTA pregnancies complicated by sFGR. In 
DC triplets with FFTS, there was survival of at least one baby in 97% of pregnancies and 
survival of 73% of all babies; these results are compatible with those of endoscopic laser 
surgery in MC twins with severe FFTS. In MC triplets with severe FFTS at least one baby 
survived in 82% of pregnancies and 39% of all babies survived; these results are worse 
than in DC triplets with FFTS because endoscopic laser surgery in MC triplets is 
considerably more difficult than in DC triplets. In our DC triplets with sFGR type II there 
was survival of at least one baby in 79% of pregnancies and survival of 52% of all babies; 
these results are compatible with findings in our series of 547 MC twin pregnancies with 
sFGR type II treated with endoscopic laser surgery. 
Conclusions of the third study 
Intrafetal laser ER from dichorionic triplet to dichorionic twins was carried out in 60 
pregnancies at 11+0 - 14+3 weeks’ gestation and pregnancy outcome was compared to 
previous studies in DCTs managed expectantly or by ER to twins or singleton with fetal 
intracardiac injection of KCl. The results showed that ER by intrafetal laser is associated 
with lower rates of miscarriage (3%) or early preterm birth at <33 weeks (9%), compared 
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to expectant management or embryo reduction by intrafetal injection of potassium 
chloride. However, about half of the pregnancies result in the birth of one rather than two 
babies. 
Final conclusions 
Endoscopic placental laser coagulation and intrafetal laser can be successfully applied in 
the management of highly complicated monochorionic twin and triplet pregnancies.  
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Conclusiones del primer estudio 
Se realizó coagulación láser endoscópica de la placenta en 547 gemelos  monocoriales 
biamniónicas (MCBA) con crecimiento intrauterino restringido selectivo tipo II (CIRs-II), 
incluyendo 405 con síndrome de transfusión feto-fetal coexistente. El gemelo pequeño 
sobrevivió en el 40% de los casos y el grande en el 69% de los casos. Los factores 
predictivos significativos para la supervivencia de ambos gemelos, grande y pequeño, 
fueron los hallazgos del Doppler del ductus venoso en el gemelo pequeño, la edad 
gestacional al momento del láser y la longitud cervical, sin embargo, ni la presencia de 
STFF o los hallazgos del Doppler en el gemelo grande se vieron relacionados. Por lo 
tanto, en el CIRs-II la supervivencia tras cirugía láser depende esencialmente de la 
condición del gemelo pequeño. 
Conclusiones del segundo estudio 
Se realizó coagulación láser endoscópica de la placenta en 11 embarazos MCTA y en 33 
embarazos BCTA complicados con STFF y en 14 embarazos BCTA complicados con 
CIRs. En gestaciones BCTA con STFF la supervivencia de al menos un feto fue del 97% 
y de todos los fetos en el 73%; estos resultados son compatibles con los de la 
coagulación láser endoscópica en gemelos MC con STFF severo. En gestaciones MCTA 
con STFF severo sobrevivió al menos un feto en el 82% de los embarazos y todos los 
fetos en el 39; estos resultados son peores que en las gestaciones DCTA con STFF 
porque la cirugía laser endoscópica en MCTA es considerablemente más complicada que 
en las gestaciones DCTA. En nuestra serie de gestaciones triples BC con CIRs-II la 
supervivencia de al menos un feto fue del 79% y de todos los fetos del 52%; estos 
resultados son compatibles con los hallazgos en nuestra serie de 547 gemelares MC con 
CIRs-II tratado con cirugía laser endoscópica. 
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Conclusiones del tercer estudio 
Se realizó reducción embrionaria (RE) con laser intrafetal de gestación triple BC a 
gemelar BC en 60% embarazos a las 11 (11-14) semanas de gestación. El resultado del 
embarazo fue comparado con estudios previos en triples BC manejados de manera 
expectante o con RE a gestación gemelar o a única con inyección intracardiaca fetal de 
cloruro de potasio (KCl). Los resultados mostraron que la RE con láser intrafetal se 
asocia a tasas más bajas de aborto espontáneo (3%) o parto prematuro < 33 semanas de 
gestación (9%), comparado con el manejo expectante o reducción embrionaria mediante 
inyección intrafetal de KCl. Sin embargo, alrededor de la mitad de los embarazos resultan 
en el nacimiento de un único feto en lugar de dos. 
Conclusiones finales 
La coagulación láser endoscópica de la placenta y el láser intrafetal pueden emplearse 
con éxito en el manejo de gestaciones gemelares MC y gestaciones triples complicadas 
!  106
CONCLUSIONS 
!  
  
!  107
REFERENCES 
!  
!108
REFERENCES 
!  
!109
REFERENCES6.
REFERENCES 
!  
 
!110
6.
REFERENCES 
!  
Abel JS, Flöck A, Berg C, Gembruch U, Geipel A: Expectant management versus 
multifetal pregnancy reduction in higher order multiple pregnancies containing a 
monochorionic pair and a review of the literature. Int J Epidemiol. 2017; 46: 324-335. 
Akkermans J, Peeters SH, Klumper FJ, Lopriore E, Middeldorp JM, Oepkes D: Twenty-
five years of fetoscopic laser coagulation in twin-twin transfusion syndrome: A systematic 
review. Fetal Diagn Ther 2015; 38: 241-253. 
Alfirevic Z, Sundberg K, Brigham S: Amniocentesis and chorionic villus sampling for 
prenatal diagnosis. Cochrane Database Syst Rev. 2003; 3: CD003252. 
Ananth CV, Chauhan SP: Epidemiology of Twinning in Developed Countries. Semin 
Perinatol 2012; 36:156-161.  
Antsaklis A, Souka AP, Daskalakis G, Papantoniou N, Koutra P, Kavalakis Y, Mesogitis S.: 
Embryo reduction versus expectant management in triplet pregnancies. J Matern Fetal 
Neonatal Med 2004; 16: 219-222. 
Aston KI, Peterson CM, Carrel DT: Monozygotic twinning associated with assisted 
reproductive technologies: a review. Reproduction 2008; 36: 377-386. 
Athanasiadis AP, Zafrakas M, Tarlatzis BC, Vaitsi V, Mikos T, Bontis J: Multifetal pregnancy 
reduction in pregnancies with a monochorionic component. Fertil Steril 2005; 88: 474-476. 
Baergen R, Benirschke K: The placenta, products of conception, and gestational 
trophoblastic disease. Chapter in Silverberg's Principles and Practice of Surgical 
Pathology  and Cytopathology. Cambridge University Press. doi:10.1017/ 
9781139137201.041 
Baschat AA, Barber J, Pedersen N, Turan OM, Harman CR: Outcome after fetoscopic 
selective laser ablation of placental anastomoses vs equatorial laser dichorionization for 
the treatment of twin-to-twin transfusion syndrome. Am J Obstet Gynecol 2013; 209:1-8. 
!111
REFERENCES 
!  
Bebbington MW, Danzer E, Moldenhauer J, Khalek N, Johnson MP: Radiofrequency 
ablation vs bipolar umbilical cord coagulation in the management of complicated 
monochorionic pregnancies. Ultrasound Obstet Gynecol 2012; 40: 319-324. 
Bejar R, Vigliacco G, Gramajo H, Solana C, Benirschke K, Berry C,  Coen R, Resnik R: 
Antenatal origin of neurologic damage in newborn babies. II. Multiple gestations. Am J 
Obstet Gynecol 1990; 162: 1230-1236. 
Benirschke K, Kim CK: Multiple pregnancy. N Engl J Med 1973; 288: 1276-1284. 
Blickstein I: Estimation of iatrogenic monozygotic twinning rate following assisted 
reproduction: Pitfalls and caveats. Am J Obstet Gynecol 2005; 192: 365-368. 
Breathnach FM, McAuliffe FM, Geary M, Daly S, Higgins JR, Dornan J, Morrison JJ, 
Burke G, Higgins S, Dicker P, Manning F, Carroll S, Malone FD, Perinatal Ireland 
Research Consortium: Optimum timing for planned delivery of uncomplicated 
monochorionic and dichorionic twin pregnancies. Obstet Gynecol 2012; 119: 50-59. 
Chalouhi GE, Marangoni MA, Quibel T, Deloison B, Benzina N, Essaoui M, Al Ibrahim A, 
Stirnemann JJ, Salomon LJ and Ville Y: Active management of selective intrauterine 
growth restriction with abnormal Doppler in monochorionic diamniotic twin pregnancies 
diagnosed in the second trimester of pregnancy. Prenatal Diagnosis 2013; 33: 109-115. 
Chang YL, Chao AS, Chang SD, Hsieh PC, Su SY, Chen KJ, Cheng PJ, Wang TH: 
Outcome of twin-twin transfusion syndrome treated by laser therapy in Taiwan's single 
center: Role of Quintero staging system. Taiwan J Obstet Gynecol 2016; 55: 700-704. 
Chauhan SP, Shields D, Parker D, Sanderson M, Scardo JA, Magann EF: Detecting fetal 
growth restriction or discordant growth in twin gestations stratified by placental 
chorionicity. J Reprod Med 2004; 49: 279-284. 
!112
REFERENCES 
!  
Chaveeva P, Kosinski P, Puglia D, Poon LC, Nicolaides KH: Trichorionic and dichorionic 
triplet pregnancies at 10–14 weeks: outcome after embryo reduction compared to 
expectant management. Fetal Diagn Ther 2013; 34: 199-205. 
Chaveeva P, Poon LC, Sotiriadis A, Kosinski P, Nicolaides KH: Optimal method and timing 
of intrauterine intervention in twin reversed arterial perfusion sequence: case study and 
meta-analysis. Fetal Diagn Ther 2014; 35:267-279 
Corbet CL, Shmorgun D: Yolk sac number does not predict reliably amnionicity in 
monochorionic twin pregnancies: a case of a monochorionic monoamniotic twin 
pregnancy with two distinct yolk sacs on early first-trimester ultrasound. Ultrasound Obstet 
Gynecol 2012; 39: 607-608. 
Couck I, Lewi L: The placenta in twin-to-twin transfusion syndrome and twin anemia 
polycythemia sequence. Twin Res Hum Genet 2016; 19: 184-190. 
De Catte L, Camus M, Foulon W: Monochorionic high-order multiple pregnancies and 
multifetal pregnancy reduction. Obstet Gynecol 2002; 100: 561-566. 
Derom C, Vlietinck R, Derom R, Van den Berghe H, Thiery M: Increased monozygotic 
twinning rate after ovulation induction. The Lancet 1987; 1: 1236-1238 
Derom C, Leroy F, Vlietinck R, Fryns JP, Derom R: High frequency of iatrogenic 
monozygotic twins with administration of clomiphene citrate and a change in chorionicity. 
Fertil Steril 2006; 85: 755-757. 
Dias T, Arcangeli T, Bhide A, Napolitano R, Mahsud-Dornan S, Thilaganathan B: First-
trimester ultrasound determination ofchorionicity in twin pregnancy. Ultrasound Obstet 
Gynecol 2011; 38: 530-532. 
Diehl W, Hecher K: Selective cord coagulation in acardiac twins. Semin Fetal Neonat Med 
2007; 12:458-463. 
!113
REFERENCES 
!  
Downing M, Sulo S, Parilla BV: Perinatal and neonatal outcomes of triplet gestations 
based on chorionicity. AJP Rep 2017; 7: 59-63. 
Drugan A, Ulanovsky I, Burke Y, Blazer S, Weissman A: Fetal reduction in triplet 
gestations: twins still fare better. Isr Med Assoc J. 2013; 15: 745-747. 
Dufendach K: Illustrates various types of chorionicity and amniosity in monozygotic twins 
as a result of when the blastocyst or embryo splits. Copyright: Creative Commons 
Attribution. 2008 
Edwards RG, Mettler L, Walters DE: Identical twins and in vitro fertilization. J In Vitro Fert 
Embryo Transf 1986; 3: 114-117. 
Emery SP, Hasley SK, Catov JM, Miller RS, Moon-Grady AJ, Baschat AA, Johnson A, Lim 
FY, Gagnon AL, Ozcan T, Luks FI, North American Fetal Therapy Network: Intervention vs 
expectant management for stage I twin-twin transfusion syndrome. Am J Obstet Gynecol 
2016; 3: 34 
Ghulmiyyah LM, Perloe M, Tucker MJ, Zimmermann JH, Eller D, Sills ES: Monochorionic-
triamniotic triplet pregnancy after intracytoplasmic sperm injection, assisted hatching, and 
two-embryo transfer: first reported case following IVF. BMC Pregnancy Childbirth 2003; 3: 
4. 
Gratacos E, Lewi L, Carreras E, Becker J, Higueras T, Deprest J, Cabero L: Incidence and 
characteristics of umbilical artery intermittent absent and/or reversed end-diastolic flow in 
complicated and uncomplicated monochorionic twin pregnancies. Ultrasound Obstet 
Gynecol 2004; 23: 456-460. 
Gratacos E, Lewi L, Munoz M, Acosta-Rojas R, Hernandez-Andrade E, Martinez JM, 
Carreras E, Deprest J: A classification system for selective intrauterine growth restriction 
in monochorionic pregnancies according to umbilical artery Doppler flow in the smaller 
twin. Ultrasound Obstet Gynecol 2007; 30: 28-34. 
!114
REFERENCES 
!  
Gratacos E, Antolin E, Lewi L, Martinez JM, Hernandez-Andrade E, Acosta-Rojas R, 
Enriquez G, Cabero L, Deprest J: Monochorionic twins with selective intrauterine growth 
restriction and intermittent absent or reversed end-diastolic flow (type III): feasibility and 
perinatal outcome of fetoscopic placental laser coagulation. Ultrasound Obstet Gynecol 
2008; 31: 669-675. 
Gratacos E, Eixsarch E, Crispi F: Diagnosis and management of selective fetal growth 
restriction in monochorionic twins. Fetal Matern Med Rev  2009 20:269-281. 
Gray PH, Cincotta R, Chan FY, Soong B: Perinatal outcomes with laser surgery for twin-
twin transfusion syndrome. Twin Res Hum Genet 2006; 9: 438-443. 
Haas J, Hourvitz A, Dor J, Yinon Y, Elizur S, Mazaki-Tovi S, Barzilay E, Shulman A: 
Pregnancy outcome of early multifetal pregnancy reduction: triplets to twins versus triplets 
to singletons. Reprod Biomed Online 2014; 29: 717-721. 
Hall JG: Twinning. The Lancet 2003; 362: 734-743.  
Hecher K, Diehl W, Zikulnig L, Vetter M, Hackelöer BJ: Endoscopic laser coagulation of 
placental anastomoses in 200 pregnancies with severe mid-trimester twin-to-twin 
transfusion syndrome. Eur J Obstet Gynecol Reprod Biol 2000; 1: 135-139. 
Hecht BR: The impact of assisted reproductive technology on the incidence of multiple 
gestations. In Multiple pregnancy. Epidemiology, Gestation and Perinatal Outcome. The 
Parthenon Publishing Group; 1995; 175-190. 
Hillman SC, Morris RK, Kilby MD: Co-twin prognosis after single fetal death: a systematic 
review and meta-analysis. Obstet Gynecol 2011; 118: 928-940. 
Huber A, Diehl W, Zikulnig L, Bregenzer T, Hackelöer BJ, Hecher K: Perinatal outcome in 
monochorionic twin pregnancies complicated by amniotic fluid discordance without severe 
twin–twin transfusion syndrome. Ultrasound Obstet Gynecol 2006; 27: 48-52. 
!115
REFERENCES 
!  
Ishii K, Murakoshi T, Takahashi Y, Shinno T, Matsushita M, Naruse H, Torii Y, Sumie 
M, Nakata M: Perinatal outcome of monochorionic twins with selective intra-uterine growth 
restriction and different types of umbilical artery Doppler under expectant management. 
Fetal Diagn Ther 2009; 26: 157-161. 
Ishii K, Murakoshi T, Hayashi S, Saito M, Sago H, Takahashi Y, Sumie M, Nakata M, 
Matsushita M, Shinno T, Naruse H, Torii Y: Ultrasound predictors of mortality 
in monochorionic twins with selective intrauterine growth restriction. Ultrasound Obstet 
Gynecol 2011; 37: 22-6. 
Khanduri S, Chhabra S, Raja A, Bhagat S: Twin Reversed Arterial Perfusion Sequence: A 
Rare Entity. J Clin Imaging Sci 2015; 5: 9. 
Kiely JL, Kiely B: Epidemiological trends in multiple births in the United States, 1971–
1998. Twin Res 2001; 4: 131-133. 
Knopman JM, Krey LC, Oh C, Lee J, McCaffrey C, Noyes N: What makes them split? 
Identifying risk factors that lead to monozygotic twins after in vitro fertilization. Fertil Steril 
2014; 102: 82-89. 
Kuhn-Beck F. Moutel G, Weingertner AS, Kohler M, Hornecker F, Hunsinger MC, Kohler A, 
Mager C, Neumann M, Nisand I, Favre R: Fetal reduction of triplet pregnancy: one or two? 
Prenat Diagn 2012; 32: 122-126. 
Lewi L, Jani J, Blickstein I, Huber A, Gucciardo L, Van Mieghem T, Doné E, Boes AS, 
Hecher K, Gratacós E, Lewi P, Deprest J: The outcome of monochorionic diamniotic twin 
gestations in the era of invasive fetal therapy: a prospective cohort study. Am J Obstet 
Gynecol 2008; 514: 1-8. 
Lewi L, Deprest J, Hecher K: The vascular anastomoses in monochorionic twin 
pregnancies and their clinical consequences. Am J Obstet Gynecol 2013; 208: 19-30. 
MacGillivray I: Epidemiology of twin pregnancy. Semin Perinatol 1986; 10: 4-8. 
!116
REFERENCES 
!  
Machin G, Bamforth F, lnnes M, Minichul K.: Some perinatal characteristics of 
monozygotic twins who are dichorionic. Am J Med Genet. 1995; 55: 71-76. 
Mahieu-Caputo D, Meulemans A, Martinovic J, Gubler MC, Delezoide AL, Muller F, 
Madelenat P, Fisk NM, Dommergues M: Paradoxic activation of the reninangiotensin 
system in twin-twin transfusion syndrome: an explanation for cardiovascular disturbances 
in the recipient. Pediatr Res 2005; 58: 685-688. 
Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ Jr, Dorman KF, 
Ludomirsky A, Gonzalez R, Gomez R, Oz U, Detti L, Copel JA, Bahado-Singh R, Berry S, 
Martinez-Poyer J, Blackwell SC, Collaborative Group for Doppler Assessment of the Blood 
Velocity in Anemic Fetuses: Noninvasive diagnosis by Doppler ultrasonography of fetal 
anemia due to maternal red-cell alloimmunization. N Engl J Med 2000; 342: 9-14. 
Martin JA, Hamilton BE, Osterman MJ, Curtin SC, Matthews TJ: Births: final data for 2013. 
Natl Vital Stat Rep 2015; 64: 1-65. 
Mateizel I, Santos-Ribeiro S, Done E, Van Landuyt L, Van de Velde H, Tournaye H, 
Verheyen G: Do ARTs affect the incidence of monozygotic twinning? Hum Reprod. 2016; 
31: 2435-2441. 
Middeldorp JM, Sueters M, Lopriore E,  Klumper FJ, Oepkes D, Devlieger R, Kanhai HH, 
Vandenbussche FP: Fetoscopic laser surgery in 100 pregnancies with severe twin-to-twin 
transfusion syndrome in the Netherlands. Fetal Diagn Ther 2007; 22: 190-194. 
Moore TR, Gale S, Benirschke K: Perinatal outcome of forty nine pregnancies 
complicated by acardiac twinning. Am J Obstet Gynecol 1990; 163: 907-912. 
Morlando M, Ferrara L, D'Antonio F, Lawin-O'Brien A, Sankaran S, Pasupathy D, Khalil A, 
Papageorghiou A, Kyle P, Lees C, Thilaganathan B, Bhide A: Dichorionic triplet 
pregnancies: risk of miscarriage and severe preterm delivery with fetal reduction versus 
expectant management. Outcomes of a cohort study and systematic review. BJOG. 2015; 
122:1053-1060. 
!117
REFERENCES 
!  
Morris RK, Selman TJ, Harbidge A, Martin WI, Kilby MD: Fetoscopic laser coagulation for 
severe twin-to-twin transfusion syndrome: factors influencing perinatal outcome, learning 
curve of the procedure and lessons for new centres. BJOG 2010; 117: 1350-1357.  
Müllers SM, McAuliffe FM, Kent E, Carroll S, Mone F, Breslin N, Dalrymple J, Mulcahy C, 
O'Donoghue K, Martin A, Malone FD: Outcome following selective fetoscopic laser 
ablation for twin to twin transfusion syndrome: an 8 year national collaborative experience. 
Eur J Obstet Gynecol Reprod Biol 2015; 191: 125-129. 
Murphy M, Hey K.: Twinning rates. The Lancet 1997; 349: 1398-1399. 
National Collaborating Center for Women’s and Children’s Health (UK): Multiple 
Pregnancy. The Management of Twin and Triplet Pregnancies in the Antenatal Period. 
Commissioned by the National Institute for Clinical Excellence. RCOG Press: London, 
September 2011. 
Neilson JP, Danskin F, Hastie SJ: Monozygotic twin pregnancy: diagnostic and Doppler 
ultrasound studies. Br J Obstet Gynaecol 1989; 96: 1413-1418. 
Nylander PPS: Frequency of multiple births. In: MacGillivray I, Nylander PPS, Corney G, 
eds. Human multiple reproduction. London: W B Saunders, 1975: 87-98. 
Pathology Outlines: Placental findings in specific newborn/fetal or maternal conditions. 
Twins. Reviewers: Mandolin Ziadie. November 2011 Copyright: (c) 2003-2011, Pathology 
Outlines.com, Inc. 
Quintero RA, Morales WJ, Allen MH, Bornick PW, Johnson PK, Kruger M: Staging of twin–
twin transfusion syndrome. J Perinatol 1999; 19: 550-555. 
Quintero RA, Bornick PW, Morales WJ, Allen MH: Selective photocoagulation of 
communicating vessels in the treatment of monochorionic twins with selective growth 
retardation. Am J Obstet Gynecol 2001; 185: 689-696. 
!118
REFERENCES 
!  
Quintero RA, Dickinson JE, Morales WJ, Bornick PW, Bermúdez C, Cincotta R, Chan FY, 
Allen MH: Stage-based treatment of twin-twin transfusion syndrome. Am J Obstet Gynecol 
2003; 188: 1333-1340. 
Roberts D, Gates S, Kilby M, Neilson JP: Interventions for twin-twin transfusion syndrome: 
a Cochrane review. Ultrasound Obstet Gynecol 2008; 31: 701-711. 
Robyr R, Lewi L, Salomon LJ, Yamamoto M, Bernard JP, Deprest J, Ville Y: Prevalence 
and management of late fetal complications following successful selective laser 
coagulation of chorionic plate anastomoses in twin-to-twin transfusion syndrome. Am J 
Obstet Gynecol 2006; 194: 796-803. 
Ruano R, Rodo C, Peiro JL, Shamshirsaz AA, Haeri S, Nomura ML, Salustiano EM, de 
Andrade KK, Sangi-Haghpeykar H, Carreras E, Belfort MA: Fetoscopic laser ablation of 
the placental anastomoses in twin twin transfusion syndrome using the ‘Solomon 
technique’. Ultrasound Obstet Gynecol 2013; 42: 434-439. 
Saunders NJ, Snijders RJ, Nicolaides KH: Twin-twin transfusion syndrome during the 2nd 
trimester is associated with small intertwin hemoglobin differences. Fetal Diagn Ther 
1991; 6: 34-36. 
Scardo JA, Ellings JM, Newman RB: Prospective determination of chorionicity, amnionicity 
and zygosity in twin gestations. Am J Obstet Gynecol 1995; 173: 1376-1380. 
Sebire NJ, Snijders RJM, Hughes K, Sepulveda W, Nicolaides KH: The hidden mortality of 
monochorionic twin pregnancies. BJOG 1997; 104: 1203-1207. 
Sebire NJ, Souka A, Skentou H, Geerts L, Nicolaides KH: Early prediction of severe twin-
to-twin transfusion syndrome. Hum Reprod 2000; 15: 2008-2010. 
Senat MV, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y: Endoscopic laser surgery 
versus serial amnioreduction for severe twin-to- twin transfusion syndrome. N Engl J Med 
2004; 351: 136-144. 
!119
REFERENCES 
!  
Sepulveda W, Sebire NJ, Hughes K, Odibo A, Nicolaides KH: The lambda sign at 10-14 
weeks of gestation as a predictor of chorionicity in twin pregnancies. Ultrasound Obstet 
Gynecol 1996; 7: 1422-1423. 
Sepulveda W, Sebire NJ, Odibo A, Psarra A, Nicolaides KH: Prenatal determination of 
chorionicity in triplet pregnancy by ultrasonographic examination of the ipsilon zone. 
Obstet Gynecol 1996; 88: 855-858. 
Shen O, Samueloff A, Beller U, Rabinowitz R: Number of yolk sacs does not predict 
amnionicity in early first-trimester monochorionic multiple gestations. Ultrasound Obstet 
Gynecol 2006; 27: 53-55. 
Shiva M, Mohammadi Yeganeh L, Mirzaagha E, Chehrazi M, Bagheri Lankarani N: 
Comparison of the outcomes between reduced and nonreduced triplet pregnancies 
achieved by Assisted Reproductive Technology. Aust N Z J Obstet Gynaecol 2014; 54: 
424-427. 
Shur N: The genetics of twinning: from splitting eggs to breaking paradigms. Am J Med 
Genet C Semin Med Genet 2009; 151: 105-109. 
Skiadas CC, Missmer SA, Benson CB, Racowsky C: Impact of selective reduction of the 
monochorionic pair in in vitro fertilization triplet pregnancies on gestational length. Fertil 
Steril 2010; 94: 2930-2931. 
Slaghekke F, Lopriore E, Lewi L, Middeldorp JM, van Zwet EW, Weingertner AS, Klumper 
FJ, DeKoninck P, Devlieger R, Kilby MD, Rustico MA, Deprest J, Favre R, Oepkes 
D:Fetoscopic laser coagulation of the vascular equator versus selective coagulation for 
twin-to-twin transfusion syndrome: an open-label randomised controlled trial. Lancet 2014; 
383: 2144-2151. 
Slaghekke F, Oepkes D: Solomon technique versus selective coagulation for twin-twin 
transfusion syndrome. Twin Res Hum Genet 2016; 3: 217-221. 
!120
REFERENCES 
!  
Society for Maternal-Fetal Medicine (SMFM), Simpson LL: Twin-twin transfusion 
syndrome. Am J Obst Gynaec 2013; 208: 3-18. 
Sperling L, Kiil C, Larsen LU, Brocks V, Wojdemann KR, Qvist I, Schwartz M, Jorgensen 
C, Espersen G, Skajaa K, Bang J, Tabor A: Detection of chromosomal abnormalities, 
congenital abnormalities and transfusion syndrome in twins. Ultrasound Obstet Gynecol 
2007; 29: 517-526. 
Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B: Randomised 
controlled trial of genetic amniocentesis in 4,606 low-risk women. Lancet 1986; 1: 
1287-1293. 
Thia E, Thain S, Yeo GS: Fetoscopic laser photocoagulation in twin-to-twin transfusion 
syndrome: experience from a single institution. Singapore Med J 2017; 58: 321-326. 
Ulug U, Jozwiak EA, Mesut A, Bener F, Bahceci M: Monochorionic triplets following 
intracytoplasmic sperm injection: A report of two consecutive cases. Gynecol Obstet 
Invest 2004, 57: 177-180. 
Van Klink JM, Koopman HM, Rijken M, Middeldorp JM, Oepkes D, Lopriore E: Long-term 
neurodevelopmental outcome in survivors of twin-to-twin transfusion syndrome. Twin Res 
Hum Genet 2016; 3: 255-261. 
Van de Mheen L, Everwijn SM, Knapen MF, Oepkes D, Engels M, Manten GT, Zondervan 
H, Wirjosoekarto SA, van Vugt JM, Erwich JJ, Nij Bijvank SW, Ravelli A, Heemelaar S, 
van Pampus MG, de Groot CJ, Mol BW, Pajkrt E: The effectiveness of multifetal 
pregnancy reduction in trichorionic triplet gestation. Am J Obstet Gynecol 2014; 
211:536.e1-e6. 
Vanderheyden TM, Fichera A, Pasquini L, Tan TY, Wee LY, Frusca T, Fisk NM: Increased 
latency of absent end-diastolic flow in the umbilical artery of monochorionic twin fetuses. 
Ultrasound Obstet Gynecol 2005; 26: 44-49. 
!121
REFERENCES 
!  
Victoria A, Mora G, Arias F: Perinatal outcome, placental pathology, and severity of 
discordance in monochorionic and dichorionic twins. Obstet Gynecol 2001; 97: 310-315. 
Ville Y, Hecher K, Ogg D, Warren R, Nicolaides KH: Successful outcome after Nd-YAG 
laser separation of chorioangiopagus-twins under sonoendoscopic control. Ultrasound 
Obstet Gynecol 1992; 2: 429-431. 
Ville Y, Hyett J, Hecher K, Nicolaides KH: Preliminary experience with endoscopic laser 
surgery for severe twin–twin transfusion syndrome. N Engl J Med 1995; 332: 224-227. 
Visentin S, Macchi V, Grumolato F, Porzionato A, De Caro R, Cosmi E. Expectant 
management in type II selective intrauterine growth restriction and abnormal cord insertion 
in monochorionic twins. J Perinat Med 2013; 41: 309-316. 
Weber MA, Sebire NJ: Genetics and developmental pathology of twinning. Semin Fetal 
Neonatal Med 2010; 15: 313-318. 
Zhao D, de Villiersa SF, Oepkes D, Lopriore E: Monochorionic twin placentas: Injection 
technique and analysis. Diagn Prenat 2014; 25: 35-42. 
!122
